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 ABSTRACT 
Congenital heart defects (CHD) are the most common birth malformation affecting about 8 
infants per 1,000 live births and is responsible for the majority of prenatal deaths. Currently, the 
fundamental cause of most CHD cases remains unknown. Congenital heart defects pose a serious 
public health concern due to the high incidence and mortality among the population. By 
improving the understanding of causation of CHD, we may better understand the pathological 
basis of the disease and find disease risk for patients and their families. 
 We conducted a forward genetic screen using ENU-induced mice in order to find the 
majority of disease-causing genes for congenital heart defects. We were able to recover a total of 
88 mutations within 62 disease-causing genes that contribute to both cardiac and non-cardiac 
mutant phenotypes from 146 mouse lines. Of these variants, 59 were missense, 16 were splicing, 
and 13 were nonsense.  
There are 21 mutations from our screen that were found to be in the same domain as 
published human mutations. The mutations are similar in the sense that they occur in the same 
protein domain, but not necessarily the same exon. These mutations also present similar 
phenotypes in both mice and humans. Three of these mutations are incredibly similar to 
published human mutations due to the fact that they are within one or two amino acids or 
nucleotides from each other. 
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 All in all, we can conclude that the 88 disease-causing mutations recovered from our 
genetic screen are mostly damaging. Three-fourths (75%) of the mutations were completely 
damaging. About 17% were possibly damaging, 2% were possibly tolerated, and 1% was 
tolerated. The remaining 5% are splicing mutations that were more than two base pairs from the 
exon and therefore did not have a definitive conservation call. Overall, there is only one mutation 
in our screen that is tolerated. This information proves that mutations which are disease causing 
occur in highly conserved locations. Mutations from our screen, especially those that are similar 
to published human mutations, are important in determining the genotype-phenotype relationship 
in congenital heart defects. 
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 1.0  BACKGROUND AND SIGNIFICANCE 
1.1 CONGENITAL HEART DEFECTS 
Congenital heart defects (CHD) are the most common birth malformation affecting about 8 
infants per 1,000 live births and is responsible for the majority of prenatal deaths (Mitchell 2007, 
Pierpont 2007). The genetic etiology and molecular mechanisms of CHD remain unknown 
despite many research studies, which suggest strong evidence for a genetic component. The 
prevalence of CHD in 2000 was estimated to be 623,000 people:  320,000 with simple lesions, 
165,000 with moderately complex disease, and 138,000 with highly complex disease (Pierpont 
2007). By improving the understanding of causation of CHD, we may better understand the 
pathological basis of the disease, find disease risk for patients and their families, and identify 
potential therapies. 
 It has been proposed that CHD is a multifactorial disease consisting of genetic, 
environmental, and teratogenic factors acting as disease modifiers (Botto 2003). Some 
teratogenic factors that may contribute to CHD include maternal folic acid intake, therapeutic 
drug exposure, PKU, and pregestational diabetes to name a few (Jenkins 2007). Most cases 
however are due to sporadic, de novo mutations as opposed to heritable, familial mutations 
making it difficult to deduce the precise cause of the phenotype. Additionally, there is a wide 
 1 
 range of phenotypes and associative diseases in CHD, which makes finding a genotype-
phenotype relationship even more difficult. 
The mechanistic complexity of CHD could account for the wide variation in phenotypes 
among humans. The genetic etiology has been hard to determine due to the limited correlation 
between the genetic mutation and the specific phenotype. Some reasons for the complexity of 
CHD include:  genetic heterogeneity in which similar cardiac defects are caused by more than 
one genetic mutation (Benson 2000); variable expressivity in which one gene may cause multiple 
phenotypes (Benson 2000); reduced penetrance where a person may be a carrier for the disease-
causing mutation but not express the CHD phenotype (Benson 1998); one or more causative 
genes for CHD associated with chromosomal alterations (Momma 1995); single gene defects 
with or without the expression of the CHD phenotype (McElhinney 2002).  
1.2 ENU FORWARD GENETIC SCREEN 
The Lo lab is conducting a large-scale forward genetic screen in mice using ethylnitrosourea in 
order to better understand the genetic etiology of congenital heart defects. Ethylnitrosourea, also 
known as ENU, is an efficient mutagen, which induces a point mutation every 1 to 2 megabases 
throughout the genome (Kile 2005). This mutation rate is approximately 100-fold higher than the 
spontaneous mutation rate and only affects a single locus, making it ideal for genetic screens. 
With the introduction of the ENU mutagen, it is now possible to accelerate the rate of 
mutagenesis in the mouse model instead of having to wait for spontaneous mutations. 
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 1.3 WHOLE EXOME SEQUENCING 
Whole exome sequencing (WES) is a technique used to identify and sequence the coding regions 
of all annotated protein coding genes (Goh 2012). It can be divided into three parts:  preparation 
of genomic DNA libraries, hybridization of these libraries, and sequencing of the hybridized 
fragments.  
 There are some downfalls to using whole exome sequencing instead of whole genome 
sequencing. Since whole exome sequencing only identifies the sequence of the coding regions 
many structural and other functional parts are not being included that may also contribute to 
disease. WES does not cover untranslated regions, enhancers, and long-noncoding RNAs, which 
may be potentially functional (Goh 2012). Structural variations such as copy number variants, 
translocations, and inversions are also not included in whole exome sequencing (Goh 2012). 
Despite these downfalls, whole exome sequencing is still widely used among researchers due to 
its cost effectiveness, robustness, and timeliness.  
 When compared to whole genome sequencing, WES costs five times less, has a higher 
coverage depth of 100x versus 30x, and requires less processing time since only a sixth of the 
genome is being analyzed (Goh 2012). Additionally, most allelic variants that have been found to 
be causal of Mendelian disorders disrupt protein-coding sequences, which can easily be found 
through exome sequencing (Ng 2010). Variants in the exome also have a larger effect size than 
those within non-coding sequences even in highly conserved regions (Ng 2010). Given all these 
reasons our lab has chosen to perform whole exome sequencing on the mutant mice. 
 3 
 1.4 EVOLUTIONARY CONSERVATION 
Evolutionary conservation is important in providing support for genes that may contribute to 
disease. Conservation means that the amino acid at a certain position is the same throughout a set 
of species. Mutations in regions that are highly conserved are more likely to cause disease than 
those that are less conserved or not conserved at all. It has been described as a basic criterion for 
examining the disease causing potential of an amino acid or nucleotide sequence change 
(Pierpont 2007). Research done by Pierpont et al. describes three criteria used to establish the 
disease causing potential of a mutation. These criteria include:  a sequence change that alters the 
gene coding sense, gene splice site, or regulatory region of the protein; segregates with disease in 
a kindred; and is not found in unrelated, unaffected control chromosomes. Some mutations may 
also be considered conserved if the changed amino acid residue has similar properties of the 
original residue. Comparisons of the sequences of the same protein in different species help to 
pinpoint those residues that are structurally or functionally vital as these will not change 
(Bolsover 2011). 
 Mutations may be tolerated, as long as the change does not destroy or seriously alter the 
protein’s function. Mutations are damaging, or possibly damaging, when changes in side chains 
that are involved in binding substrates or cofactors, that interact with other proteins, or that 
participate in catalytic mechanisms alter or destroy the protein’s function (Betts 2003).  
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 1.5 SPECIFIC AIMS 
The objective of this study was to examine the disease-causing genes recovered from our ENU 
forward genetic screen looking at evolutionary conservation and specific protein domains. The 
objectives were accomplished by fulfilling the following aims: 
Aim 1: 
Determine if the disease-causing mutations recovered in the ENU screen are evolutionarily 
conserved throughout a set of species and the damaging status of the mutation. 
Aim 2: 
Determine the protein domain, if any, in which the mutation is located and explain how a 
mutation in this domain may cause the observed phenotype. 
Aim 3: 
Compare recovered disease-causing ENU mutations with published human mutations to 
determine if any of the mouse mutations are the same as those in humans or located in the same 
protein domain and associated with a similar CHD phenotype. 
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 2.0  MATERIALS AND METHODS 
2.1 ENU MOUSE BREEDING 
G0 males are injected with the alkylating agent N-ethyl-N-nitrosourea (ENU).  These males are 
crossed with a wild type C57BL6 female to generate G2 progeny. ENU mutagenized G0 males 
are backcrossed to their G2 daughters to generate G3 progeny. Pregnant G2 mothers are checked 
for G3 fetuses with congenital heart defects by ultrasound. Heart defects among other 
phenotypes should be found in G3 mice with homozygous mutations caused by the ENU 
mutagenesis. See Figure 1 for the full breeding scheme. 
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Figure 1. ENU breeding scheme. 
Please note that this figure was adapted from a figure presented by Dr. You Li in the Lo lab. 
2.2 MUTATION RECOVERY BY EXOME SEQUENCING 
Mice that are phenotypically abnormal based on ultrasound screening, necropsy, and EFIC are 
sent out for full exome sequencing. Once the sequencing reads are retrieved by You Li, they 
must be filtered and sorted. Reads must be mapped to the genome and variants are detected by 
their deviation from the mouse genome. Reads that have low coverage across the exome are 
generally filtered out of the data due to the lack of accuracy. Next, the reads are annotated with 
their chromosomal location and nucleotide or amino acid change. Annotated mutations are then 
sorted based on the type:  nonsynonymous (i.e. missense), frameshift (i.e. nonsense), and 
splicing. These reads are filtered against the dbSNP129 database and the Lo lab in house 
 7 
 database. We may then determine candidate disease causing genes based on their zygosity and 
are confirmed through next generation sequencing (NGS). Please refer to Figure 2 for the whole 
exome sequencing pipeline, which describes the technique in full. 
 
 
Figure 2. Whole exome sequencing pipeline 
Please note that this figure was adapted from a figure presented by Dr. You Li in the Lo lab. 
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 2.3 DISEASE-CAUSING GENE VALIDATION 
Genes were validation for disease-causing status by genotyping of the mutant pup and its 
littermates. Please note that Nikolai Klena, a lab tech in the Lo lab, validated disease-causing 
genes. The recovered disease-causing genes are homozygous in the exome sequencing and this 
must be validated through genotyping. Once the mutant pup has been genotyped for the specific 
gene and homozygosity has been established we must genotype the littermates. The purpose of 
genotyping the littermates are to clarify that this mutation is actually causing the observed 
phenotype. If the mutation is present as homozygous in any of the littermates that do not have the 
observed mutant phenotype, then this mutation must not be causing the phenotype. 
2.4 PROTEIN DOMAINS 
Protein domains for each gene are determined using SMART, a Simple Modular Architecture 
Research Tool. This is a biological database that allows researchers to view the domain 
architecture of evolutionarily conserved protein domains. By inserting the entire amino acid 
sequence of the gene of interest, SMART comes up with a set of domains that are within that 
gene as well as the number and position of amino acids that are within that domain. The protein 
domain for the variants we recovered is found by looking at the location of the amino acid 
change in the mutation and comparing it with the location of the SMART domain for that gene. 
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 2.5 CONSERVATION CALLS 
There are four different conservation calls that could be made: damaging, possibly damaging, 
tolerated, and possibly tolerated. Conservation calls were made based on four criteria.  A variant 
is considered damaging and thus highly conserved if the amino acid is the same across all 
species. If the amino acid is different among any of the species, we examine what the wild type 
amino acid for that particular species is compared to our recovered variant. If the wild type 
amino acid in a species is the same as the amino acid change in our variant, then it is not 
considered conserved and the call would be tolerated. If the wild type amino acid is different 
than the amino acid change in our variant, then we move on to the next rule. Next, we look at the 
type of amino acid change in our variant. If the amino acid change affects certain residue 
properties, then the conservation call would be possibly damaging. If the amino acid change does 
not affect these properties, then the conservation call would be possibly tolerated. Residue 
properties include:  charge, size, structure, hydrophobicity, and polarity. 
 Splicing mutation calls are a bit different than the conservation calls for missense and 
nonsense mutations. Any splicing mutations that are within two base pairs of the exon are 
considered damaging, as these sites are canonical splice sites and the nucleotides at these 
positions are (generally) the same in every species. Any splicing mutation that is more than two 
base pairs from the exon does not have a conservation call. However, we still need to look at 
these locations to determine if the nucleotide change is present as wild type in any of the other 
species. 
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 3.0  RESULTS 
3.1 MUTATION RECOVERY 
We have been able to recover over 9,200 mutation variants from nearly 150 mutant mouse lines 
through our ENU mutagenesis screen. Variants were recovered using whole mouse exome 
sequencing analysis to find coding mutations. This strategy has proven highly effective in 
providing a non-gene biased view of the genetic etiology of congenital heart disease. Out of the 
9,235 mutations we recovered, only 1,338 (15%) of them were homozygous. We focused the rest 
of our research on analyzing the homozygous mutations.  
 Out of the 1,338 homozygous variants we recovered 96 (7.2%) disease-causing variants 
from sixty-two genes. Of these variants, 59 were missense, 16 were splicing, and 13 were 
nonsense. There were 8 variants that are the same; either occurring in the same mouse line but 
different mice or in different mouse lines. This gives us a final count of 88 disease-causing 
variants in 62 genes. Genes that had missense repeat variants include Adamts6, Armc4, Bicc1, 
and Smarca4. Genes that had splicing repeat variants are Cyp2c44 and Kif15. There was a 
nonsense mutation repeat in the Dnah11 gene. Please refer to Table 1 to see all 88 variants that 
were recovered from the screen. 
 
 11 
 Table 1. Disease-causing mutations recovered from ENU mouse screen. 
Gene Chr Exon Nucleotide change 
Amino acid 
change Strand Domain Phenotype 
Conservation 
Calls 
22410089 
E03Rik 15 
Exon 
8 T757C S253P forward unknown Joubert Syndrome damaging 
6030429 
G01Rik 7 
Exon 
7 G710A G237D reverse - Laterality 
Possibly 
damaging 
Acan* 7 Exon 6 T1032A Y344X forward LINK 
Biventricular 
hypertrophy/ 
cleft palate/ 
crachyposidm 
damaging 
Adamts6* 13 Exon 3 C447G S149R forward 
Pep_M12B_
propep 
OFT/AVSD 
septal defects/ 
hypertrophy/ 
hydronephrosis 
damaging 
Anks6 4 Exon 2 T560A M187K reverse ANK OFT/Laterality damaging 
Ap1b1* 11 Exon 9 T1094C V365A forward Adaptin_N Laterality damaging 
Armc4 18 Exon 20 T2978A M993K reverse ARM Laterality 
Possibly 
damaging 
Bicc1 10 - 606+2T>C - reverse intronic Laterality damaging 
Bicc1 10 Exon 6 T586C S196P reverse KH Laterality 
Possibly 
damaging 
Cc2d2a 5 Exon 23 C2845T R949X forward unknown 
Mild laterality/ 
cystic kidney 
and lung 
damaging 
Ccdc151 9 Exon 7 828+2T>C - reverse intronic Laterality damaging 
Ccdc39 3 Exon 4 G445T E149X reverse unknown AVSD/Laterality damaging 
Ccdc39 3 Exon 4 357+2T>A - reverse 
intronic/ 
CCD Laterality damaging 
Ccdc39 3 Exon 1 T2A M1K reverse unknown SIT damaging 
Cep110* 2 Exon 13 T1886C I629T forward unknown OFT/cranio 
Possibly 
damaging 
Cep290 10 Exon 34 T4670A L1557X forward CCD 
Mild laterality/ 
cystic kidney damaging 
Cep290 10 Exon 12 
1189+ 
2T>C - forward 
intronic/ 
CCD Laterality damaging 
Cfc1 1 Exon 2 T68A V23E forward unknown Laterality 
Possibly 
damaging 
Cml5* 6 Exon 3 A289T I97F reverse 
FR47/Acetyl 
transf_1 Laterality damaging 
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 Cxcr4* 1 Exon 2 G295A D99N reverse 7tm_1 
Left heart 
obstructive defects 
Possibly 
damaging 
D630037 
F22Rik* 10 
Exon 
10 
1071+ 
2T>A - reverse intronic 
Laterality/OFT/ 
polydactyly damaging 
Dctn5* 7 Exon 4 348+6T>C - forward intronic 
DORV/VSD/ 
overriding aorta N/A 
Dnah11 12 Exon 16 C3184T Q1062X reverse Spc7 Laterality damaging 
Dnah11 12 Exon 63 C10243T Q3415X reverse MYSc PCD/Laterality damaging 
Dnah11 12 Exon 60 T9837A Y3279X reverse MYSc Laterality/OFT damaging 
Dnah11 12 Exon 7 1137+T>C - reverse 
intronic/ 
DHC_N1 Laterality damaging 
Dnah11 12 Exon 40 
6489+ 
2T>C - reverse 
intronic/ 
AAA_5 Laterality damaging 
Dnah11 12 Exon 64 A10369T I3457F reverse MYSc PCD/Laterality damaging 
Dnah11 12 Exon 33 A5632G T1878A reverse AAA Laterality damaging 
Dnah11 12 Exon 41 T6641G L2214R reverse AAA_5 Laterality 
Possibly 
damaging 
Dnah5 15 Exon 4 438+2T>A - forward intronic PCD/Laterality damaging 
Dnah5 15 Exon 44 
7398+ 
2T>A - forward intronic Laterality damaging 
Dnah5 15 Exon 76 T13169C L4390P forward dynein heavy PCD/Laterality damaging 
Dnah5 15 Exon 59 T10048C S3350P forward DHC_N1 
DORV/AVSD/ 
Laterality damaging 
Dnah5 15 Exon 34 T5503C W1835R forward BRLZ/FYVE PCD/Laterality damaging 
Dnah5 15 Exon 48 T7971G N2657K forward AAA PCD/Laterality damaging 
Dnah5 15 Exon 76 T13210A S4404T forward 
dynein 
heavy PCD/Laterality damaging 
Dnah5 15 Exon 77 
13329= 
10T>A - forward 
intronic/ 
dynein heavy PCD/Laterality N/A 
Dnah5 15 Exon 19 C2755A H919N forward MBT/L27 PCD/Laterality tolerated 
Dnaic1 4 - 240+1G>A - forward intronic 
AVSD/DORV/ 
Laterality/ 
dextrocardia 
damaging 
Dnaic1 4 Exon 16 T1565C I522T forward unknown Laterality 
 
damaging 
 
Table 1 Continued 
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 Dync2h1 9 Exon 5 T701A V234E reverse DHC_N1 Mild Laterality 
Possibly 
damaging 
Dyx1c1 9 Exon 1 T2A M1K forward unknown Laterality 
Possibly 
damaging 
Foxj1* 11 Exon 2 T425A I142N reverse FH Laterality damaging 
Frem2 3 Exon 11 A6875G Y2292C reverse Calx-beta 
Kidney agenesis/ 
syn-polydactyly damaging 
Fuz 7 Exon 4 387+2T>A - forward intronic 
Pulmonary atresia/ 
polydactyly damaging 
Gm1060* 5 Exon 15 A2021G Y674C forward unknown Laterality damaging 
Gm1060* 5 Exon 15 T2033A L678Q forward unknown 
SIT/cranio/ 
hypertrophy damaging 
Gm572* 4 Intron 1 26+1G>A - forward intronic Laterality damaging 
Hace1* 10 Exon 19 A2060T Y687F forward HECTc 
RAA/DORV/ 
VSD damaging 
Hectd1* 12 Exon 22 T3264A Y1088X reverse unknown 
VSD/aortic atresia/ 
hypoplastic 
aortic arch 
damaging 
Hr* 14 Exon 13 G2732A W911X forward unknown SIT damaging 
Ift140 17 Exon 9 A1138G N380D forward unknown Laterality damaging 
Ift74* 4 Exon 19 T1645C W549R forward unknown Laterality damaging 
Kif7 7 Exon 3 T557A V186E reverse KISc OFT/VSD damaging 
Lox* 18 Exon 3 G854T C285F reverse 
Lysyl_ 
oxidase 
Diaphragmatic 
hernia damaging 
Lrp1 10 Exon 82 T12694C C4232R reverse EGF 
Left heart 
obstructive defects/ 
valvular anomalies 
damaging 
Lrp2 2 Exon 46 
8456-
3A>G - reverse 
intronic/ 
LDLa OFT/omphaloceol N/A 
Ltbp1* 17 Exon 7 T1134A C378X forward unknown 
OFT/cranio/ 
cystic kidney damaging 
Megf8 7 Exon 21 A3641T N1214I forward EGF Laterality damaging 
Megf8 7 Exon 3 A442G N148D forward 
EGF_ 
Lam 
SIT/AVSD/ 
DORV/ 
dextrocardia 
Possibly 
damaging 
Mical1* 10 Exon 22 T2786C M929T forward 
DUF 
3585 Laterality 
Possibly 
damaging 
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 Mmp21* 7 Exon 2 G530T W177L reverse ZnMc Laterality 
Possibly 
tolerated 
Nek8 11 Exon 3 T371C I124T reverse S_TKc Laterality damaging 
Pcsk5* 19 Exon 4 A521G D174G reverse Peptidase_S8 
Laterality/OFT/ 
cystic kidney damaging 
Pcsk5* 19 Exon 35 T4795A C1599S reverse FU 
DORV/VSD/ 
aortic stenosis damaging 
Pde2a* 7 Exon 23 T2045G M682R forward HDc 
OFT/ 
valvular anomalies damaging 
Pkd1 17 Exon 38 T11084A I3695N forward unknown PKD damaging 
Plxnd1* 6 Exon 27 A4727G D1576G reverse 
Plexin_ 
cytopl 
AVSD/ASD/VSD/
RAA/PTA 
Possibly 
damaging 
Prickle1 15 Exon 5 G482T C161F reverse LIM 
Velocardiofacial 
syndrome damaging 
Pskh1* 8 Exon 2 T656C L219P forward S_TKc Laterality damaging 
Psme4* 11 Exon 28 A3247G I1083V forward unknown Laterality damaging 
Robo1* 16 Exon 6 T809C I270T forward IGc2 
Bilateral duplex 
cystic kidney/ 
anophthalmia 
damaging 
Sema6a* 18 Exon 10 T823C S275P reverse Sema Laterality damaging 
Smad6* 9 Exon 4 A982T K328X reverse unknown OFT damaging 
Smarca4 9 Exon 16 C2381T T794I forward 
DEXDc & 
SNF2_N OFT damaging 
Smarca4 9 Exon 8 C1249T R417C forward 
Low 
complexity OFT damaging 
Snx17* 5 Exon 5 A431G E144G forward B41 OFT 
Possibly 
damaging 
Spata5* 3 Exon 9 C1493T T498I forward AAA Laterality damaging 
Sufu* 19 Exon 4 T530A M177K forward SUFU 
Polydactyly/cleft 
lip/domed head damaging 
Tab1* 15 Exon 9 T935A M312K forward PP2Cc DORV damaging 
Tmem67 4 Exon 11 T1120A Y374N reverse Meckelin 
Laterality/ 
cystic kidney 
Possibly 
damaging 
Tmem67 4 Exon 23 
2322+6T>
C - reverse 
intronic/ 
Meckelin Laterality N/A 
Tpbpa* 13 Exon 3 T162A S54R reverse - 
AVSD/DORV/ 
IAA/ 
noncompaction 
Possibly 
damaging 
Table 1 Continued 
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 Wdr69* 1 Exon 2 T57A Y19X rorward unknown 
Laterality/kidney 
tubule cysts damaging 
Wdr69* 1 Exon 3 T197C L66P forward unknown Laterality 
Possibly 
damaging 
Xpnpep1* 19 Exon 15 T1246C S416P reverse 
Peptidase_M
24 Unbalanced AVSD damaging 
Zfp161* 17 Exon 3 C419A S140X forward unknown 
DORV/ 
septal defects damaging 
Please see Appendix A for full domain information and phenotype acronyms. 
Pink highlighted genes are known to contribute to CHD. 
*novel CHD genes not associated with any human disease. 
 
3.2 CONSERVATION CALLS FOR MISSENSE AND NONSENSE MUTATIONS 
The tables in this section encompass the conservation for the region surrounding the mutation. 
Based on the conservation at the position of the mutation in addition to the conservation of the 
surrounding region, we can identify whether the mutation is damaging and how this mutation 
may affect the reading frame, particularly in nonsense mutations. DNA is read from the 5’ to 3’ 
end of the strand. The first line of each table shows which way the amino acid sequence is read. 
A sequence that is read 5’ to 3’ is on the forward strand and a sequence that is read 3’ to 5’ is on 
the reverse strand. The yellow highlighted region of each of the tables is where the mutation 
occurs. Any amino acids highlighted in red are deviations from the wild type amino acid in mice. 
Nonsense mutations are always considered damaging because they introduce a stop codon, 
which may truncate the coded protein and cause the observed phenotype. It is important to look 
at the location of the nonsense mutation to see where the stop codon is introduced in the exon. 
The following figure (Figure 3) shows the distribution of conservation across all 88 mutations.  
Table 1 Continued 
 16 
  
Figure 3. Pie graph of the conservation calls. 
3.2.1 2410089E03Rik missense mutation 
The 2410089E03Rik missense mutation is located in exon 8 at position 253 (S253P) of this gene, 
which changes a serine into a proline. Based on the conservation in Table 2, this missense 
mutation is highly conserved across all species and therefore is considered a damaging mutation. 
Table 2. 2410089E03Rik missense mutation in exon 8 is damaging. 
 
Mouse 
5’--------------------------3’ 
ECPLCSLIPRCASVKSRGALISAFSRDGLAL 
Rat ECRLCNLIPKCASVKSRGALISAFSRDGLAL 
Human DCHLCSLIPKCESVKSRGALISAFSRDGLTL 
Orangutan DCHLCSLIPKCESVKSRGALI========== 
Dog NCHLCNLIPKCASVKSRGALISAFSRDGVTL 
Horse DCLLSSLIPKCESVKSRGALISAFSRDGLTL 
Opossum ECFLCTLVPKCESIKSRGALIIAFSRDGLTL 
Chicken TCSLEKLVLTCVSIKSRGALL========== 
Stickleback TYPMSRLTPPCQPVKSRGALLPAFSPDGCLL 
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 3.2.2 6030429G01Rik missense mutation 
The missense mutation in the 6030429G01Rik gene is located in exon 7 at position 237 
(G237D). The mutation is conserved across all species except for the opossum. The wild type 
amino acid for mouse is a glycine. The mutation recovered in this gene changes the small, 
hydrophobic, nonpolar glycine into a negatively charged, acidic, polar aspartic acid. This 
changes several properties of the original residue and is thus possibly damaging. 
Table 3. 6030429G01Rik missense mutation in exon 7 is possibly damaging. 
 
Mouse 
3’--------------------------5’ 
NPVHYASLDRLEFAVGTDRWRRFEQIHIVQA 
Rat NPVHYASLDRLEFAVGTDRWRRFEHFHIVQA 
Human NPVHYASSDRLEFAVGTDRWRRFEQPHIVQA 
Orangutan NPVHYASSDRLEFAVGTDRWRRFEQPHIVQA 
Dog NPVHYASSDRLEFAVGTDRWRRFERTHIVRA 
Horse NPVHYASSDRLEFAVGTDRWRRFERTHIVRA 
Opossum NPVHYASADRIEFAVSTERWRRFERSNIVRA 
Chicken  
Stickleback =============================== 
3.2.3 Acan nonsense mutation 
The mutation in the Acan gene is considered damaging since it is a stopgain mutation which 
inserts an early stop codon at the end of exon 6 at position 344 (Y344X). 
Table 4. Acan damaging nonsense mutation is located at the end of exon 6 in a fairly conserved 
region. 
 
Mouse 
5’--------------------------3’ 
VYLHANQTGYPDPSSRYDAICYTG…intron 
Rat VYLHANQTGYPDPSSRYDAICYTG…intron 
Human VYVHANQTGYPDPSSRYDAICYTG…intron 
Orangutan VYVHANQTGYPDPSSRYDAICYTG…intron 
Dog VYLHANQTGYPDPSSRYDAICYTG…intron 
Horse VYLHANQTGYPDPSSRYDAICYTG…intron 
Opossum VYLHANQTGYPDPLSRYDAICYTG…intron 
Chicken VYLPANQTGYPHPSSRYDAICYSG…intron 
Stickleback VYLPPNQTGYPNPDSRYEAVCFGG…intron 
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 3.2.4 Adamts6 missense mutation 
The Adamts6 mutation is present in three different mouse lines. The wild type amino acid in 
mice is a serine, which is conserved throughout the entire set of species. The mutation occurs at 
the end of exon 3 at position 149 (S149R) and is considered a damaging mutation. 
Table 5. Adamts6 missense mutation in exon 3 is damaging. 
 
Mouse 
5’-----------------------3’ 
TGYLQDQHSTTKVALSNCVGL…intron 
Rat TGYLQDQHSTTKVALSNCVGL…intron 
Human TGYLQDQRSTTKVALSNCVGL…intron 
Orangutan TGYLQDQRSTTKVALSNCVGL…intron 
Dog TGYLQDQRSTTKVALSNCIGL…intron 
Horse TGYLQDQRSTTKVALSNCVGL…intron 
Opossum TGYLQDQHSTTKVAISNCIGL…intron 
Chicken TGYLQDQHTTTKVAVSNCNGL…intron 
Stickleback VGSLQNQRGATRVALSNCKGL…intron 
3.2.5 Anks6 missense mutation 
A missense mutation was recovered in the Anks6 gene that is located on chromosome 4. The 
mutation is in exon 2 of the gene at position 187 (M187K). The wild type amino acid is a 
methionine, which is conserved throughout all species; making this a damaging mutation. 
Table 6. Anks6 missense mutation in exon 2 is damaging. 
 
Mouse 
3’--------------------------5’ 
MLLRVVAEHGHQVAAMLATIGLLEDGSGGTA 
Rat MLLRVVAEHGHQVAAMLATIGLLEDRSGGSA 
Human MLLRVVAEHGHQIAAMLATIDLPEDRSGGLG 
Orangutan MLLRVVAEHGHQIAAMLATIDLPEDRSGGLG 
Dog MLLRVVAEHGHQIAAMLATIDLLEDRSDGAG 
Horse MLLRVVAEHGHQIAAMLATIDLREDRSDGAG 
Opossum VLLHVVAEHGHQAAIMLATIDPLDEKNGD-G 
Chicken LLLHVVAEHGHQAAAMLPTIDPLDDRSSNVN 
Stickleback LLLRVAAEHGHQSAVMLATIDMF—-RGG=== 
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 3.2.6 Ap1b1 missense mutation 
The Ap1b1 mutation is conserved throughout the species and is also in a highly conserved 
region; therefore it is a damaging mutation. It is located at the beginning of exon 9 at position 
365 (V365A). 
Table 7. Ap1b1 missense mutation in exon 9 is damaging and in a highly conserved region. 
 
Mouse 
5’----------------===----------3’ 
Intron…VLAELKEYATEVDVDFVRKAVRAIGRC 
Rat Intron…VLAELKEYATEVDVDFVRKAVRAIGRC 
Human Intron…VLAELKEYATEVDVDFVRKAVRAIGRC 
Orangutan Intron…VLAELKEYATEVDVDFVRKAVRAIGRC 
Dog Intron…VLAELKEYATEVDVDFVRKAVRAIGRC 
Horse Intron…VLAELKEYATEVDVDFVRKAVRAIGRC 
Opossum Intron…VLAELKEYATEVDVDFVRKAVRAIGRC 
Chicken Intron…VLAELKEYATEVDVDFVRKAVRAIGRC 
Stickleback Intron…VLAELKEYATEVDVDFVRKAVRAIGRC 
3.2.7 Armc4 missense mutation 
We recovered one missense mutation in the Armc4 gene in two different mouse lines. This 
mutation occurs in the eighth amino acid from the end of exon 20 at position 993 (M993K). The 
wild type amino acid, methionine, is conserved throughout all species except the dog. When we 
look at the amino acid change in our mutation the nonpolar, hydrophobic methionine is 
converted into a positive, polar lysine. Since there is a change in the charge and polarity, this 
mutation is possibly damaging. 
Table 8. Armc4 missense mutation in exon 20 is possibly damaging. 
 
Mouse 
3’-------------------------5’ 
Intron…KVAGNEHMTICNDADESLQYLAQ 
Rat Intron…KVAGNEHMTICNDADESLQYLAQ 
Human Intron…KVAGNEHMTICNDADESLQYLAQ 
Orangutan Intron…KVASNEHMTICNDADESLQYLAQ 
Dog Intron…KVAGNEHITICNDADESLQYLAQ 
Horse Intron…KVAGNEHMTICNDADESLQYLAQ 
Opossum Intron…KVAGNEHMTICNNADESLQYLAQ 
Chicken Intron…KVVGNEHMTICNSPDESLQYLAQ 
Stickleback Intron…KVVGRDHMTICNNPD======== 
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 3.2.8 Bicc1 missense mutation 
The Bicc1 mutation is located at the twelfth amino acid of exon 6 at position 196 (S196P). The 
wild type amino acid is a serine, which is conserved in all species except the stickleback. The 
mutation is, however, located in a fairly conserved region considering it is towards the end of the 
exon. Our recovered mutation changes from a polar, uncharged, hydrophilic serine to a nonpolar, 
uncharged proline. Since there is a change in the polarity, this mutation is possibly damaging. 
Table 9. Bicc1 missense mutation in exon 6 is possibly damaging. 
 
Mouse 
3’--------------------------5’ 
Intron…RIRARASEVGAPQGAISV…intron 
Rat Intron…RIRARASEVGAPQGAISV…intron 
Human Intron…RIRVRASEVGAPQGAISV…intron 
Orangutan Intron…RIRVRASEVGAPQGAISV…intron 
Dog Intron…RIRVRASEVGAPQGAISV…intron 
Horse Intron…RIRVRASEVGAPQGAISV…intron 
Opossum Intron…RIRVRASEVGAPQGAISV…intron 
Chicken Intron…RIRVRASEVGAPQGAISV…intron 
Stickleback Intron…RIKVRAAEVGGPQGAISV…intron 
3.2.9 Cc2d2a nonsense mutation 
The Cc2d2a nonsense mutation is located 5 amino acids into exon 23 at position 949 (R949X). 
This mutation is automatically considered damaging because it inserts a stop codon fairly early 
on in the exon. If you also look at the conservation for this mutation, it is conserved across all 
species. 
Table 10. Cc2d2a nonsense mutation in exon 23 is damaging and in a fairly conserved region. 
 
Mouse 
5’---------------------3’ 
Intron…DYEKRLRDRNVIETKDHLD 
Rat Intron…DYEKRLRDRNVIETKDHLD 
Human Intron…DYEKRLRDRNVIETKEHID 
Orangutan Intron…DYEKRLRDRNVIETKEHID 
Dog Intron…DYEKRLQDRNVIETKDHID 
Horse Intron…DYEKRLRDRNVIETKDHID 
Opossum Intron…DYEKRIRDRGIIETKDHLD 
Chicken Intron…EYEKRLHERDVIDSKHYLD 
Stickleback Intron…DYEKRLKEGETVDTEEHLD 
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 3.2.10 Ccdc39 missense and nonsense mutations 
The missense mutation in the Ccdc39 gene is located at the first amino acid in exon 1 of this 
gene. The wild type amino acid is a methionine, which is conserved throughout all species; 
therefore the mutation is damaging. 
Table 11. Ccdc39 missense mutation in exon 1 is damaging. 
 
Mouse 
3’------------------5’ 
AFGDEWHLESLFESCM…intron 
Rat AFGDEWHLESLFESSM…intron 
Human AFGDEWHLEALFESSM…intron 
Orangutan AFGDEWHLEALFESSM…intron 
Dog AFGDDWHLEELLESSM…intron 
Horse AFGDEWHLEALFESSM…intron 
Opossum AFGNEWHLESLFDQSM…intron 
Chicken AFGDDWQLEALV----…intron 
Stickleback ================…intron 
  
The nonsense mutation in Ccdc39 is located in exon 4 at position 149 (E149X). It 
introduces a stop codon in exon 4 and is considered damaging. This  
Table 12. Ccdc39 nonsense mutation in exon 4 is conserved in all species except stickleback and 
is located in a highly conserved region. 
 
Mouse 
3’-------------------------5’ 
SYKQLTLSDSDKHASEELWAELAQQDWNMQC 
Rat SYKQLTLSDSDKHASEELWAELAQQDWNMQC 
Human AYKQLTLADSDKHASEELWAELAQQDWNMQC 
Orangutan AYKQLTLADSDKHASEELWAELAQQDWNMQC 
Dog AYKQLTLADSDKHASEELWAELAQQDWNIQC 
Horse AYKQLTLADSDKHASEELWAELAQQDWNMQR 
Opossum TYKQLAFADSDKHASEELWAELAQQDWNMQC 
Chicken AYKQITIIDNDKRESEKIWSELVEEDCNMQQ 
Stickleback AYKIIAMTDEDKCNSDQLFADMTQQDWNMQN 
3.2.11 Cep110 missense mutation 
Cep110 has one missense mutation located in exon 13 at position 629 (I629T). The wild type 
amino acid is an isoleucine in mouse, rat, human, and orangutan. The wild type amino acid is a 
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 valine in dog, horse, opossum, and chicken. The recovered mutation converts the aliphatic, 
nonpolar isoleucine to a polar, uncharged, hydrophilic threonine. Since there is a change in 
polarity, this mutation is possibly damaging. 
Table 13. Cep110 missense mutation in exon 13 is possibly damaging. 
 
Mouse 
5’----------------------------3’ 
ALKKDLEGVSGLQEYLGTIKGQATQAQNECRKLQ 
Rat ALKKDLEGVSGLQEYLGTIKGQAAQAQNECRKLQ 
Human ALKKDLEGVSGLQEYLGTIKGQATQAQNECRKLR 
Orangutan ALKKDLEGVSGLQEYLGTIKGQATQAQNECRKLQ 
Dog ALKKDLESVSGLQEYLGTVKGQAPQAQNECRKLQ 
Horse ALKKKLEGVSGLQEYLGTVKGQAAQAQNECRKLQ 
Opossum TLKKNLESISGLQDYLENVKGQVTKVNDECRVLQ 
Chicken ALKRDLESIIGLQEYLESVKHQAKQAQDECKELQ 
Stickleback  
3.2.12 Cep290 nonsense mutation 
The Cep290 nonsense mutation introduces a stop codon at the end of exon 34 at position 1557 
(L1557X). The mutation is not completely conserved across all species; there is a different wild 
type amino acid in the stickleback. It is still considered damaging because it introduces an early 
stop codon, which will truncate the protein that is coded for by this gene.  
Table 14. Cep290 nonsense mutation is located at the end of exon 34 in a fairly conserved region 
and is conserved throughout all species except the stickleback. 
 
Mouse 
5’------------------------------3’ 
TIANMQARLNHKEEVLKKYQHLLEKARE…intron 
Rat TIANMQARLNHKEEVLKKYQHLLEKARE…intron 
Human TIANMQARLNQKEEVLKKYQRLLEKARE…intron 
Orangutan TIANMQARLNQKEEVLKKYQRLLEKARE…intron 
Dog TIANMQARLNQKEEVLKKYQHLLEKARE…intron 
Horse TIANMQARLNHKEEVLKKYQRLLEKARE…intron 
Opossum TIANMQARLDQKEEVLKKYQHLLEKARE…intron 
Chicken TIANMQARLSQKEEMLKKYQDLLAKARE…intron 
Stickleback TIRDLQARLNKKEDVIKKCHNQLAGARQ…intron 
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 3.2.13 Cfc1 missense mutation 
The Cfc1 missense mutation is not conserved across the species. It occurs at the end of exon 2 at 
position 23 (V23E). This gene is only present in three species:  mouse, orangutan, and horse. 
There is a different wild type amino acid than the valine in the horse. If we look at our recovered 
mutation, the nonpolar valine is converted into a polar, negatively charged aspartic acid. Since 
there is a change in charge and polarity, this mutation is considered possibly damaging. 
Table 15. Cfc1 missense mutation in exon 2 is possibly damaging. 
 
Mouse 
5’--------------------------3’ 
Intron…RPLFLVTVALQLIGLGYS…intron 
Rat Intron…==================…intron 
Human  
Orangutan Intron…RLLFMVSLALQIISLGNS…intron 
Dog  
Horse Intron…RLLFMITLALQVIHLGNS…intron 
Opossum  
Chicken  
Stickleback  
3.2.14 Cml5 missense mutation 
Cml5 has a missense mutation in exon 3 at position 97 (I97F). This gene is only present in four 
out of the nine species in the set:  mouse, rat, opossum and chicken. The recovered mutation is 
highly conserved across these four species and is therefore considered damaging.  
Table 16. Cml5 missense mutation in exon 3 is damaging. 
 
Mouse 
3’-------------------------5’ 
EAVWFSGHANLYSRTIDAMDTQLCQAVYDKF 
Rat EAVWFSGHANLYSKTIDAMDTQLCMAVYEKF 
Human  
Orangutan  
Dog  
Horse  
Opossum EAVWFSGKDSLYSKRIDRMDTHLAHDVYDSY 
Chicken EVVWFSDPARMYFSDIDRLD--SCREFST-- 
Stickleback  
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 3.2.15 Cxcr4 missense mutation 
The Cxcr4 gene has a missense mutation in exon 2 at position 99 (D99N). It is conserved in all 
species except for the dog. In our recovered mutation, the polar, negatively charged aspartic acid 
is mutated into a polar, uncharged asparagine. This mutation is considered possibly damaging 
because there is a change in charge between the wild type amino acid and the mutated amino 
acid. 
Table 17. Cxcr4 missense mutation in exon 2 is possibly damaging. 
 
Mouse 
3’-------------------------5’ 
VAKCLFKGFYWDAMADVAWFPLTIVFLLDAV 
Rat VAKCLFKGFYWDAMADVAWFPLTIVFLLDAV 
Human VAKCLFNGFYWNAVADVAWFPLTIVFLLDAV 
Orangutan VAKCLFNGFYWNAVADVAWFPLTIVFLLDAV 
Dog VAKCLFNGFYWNAVAEVAWFPLTLVFLLDAV 
Horse VAKCLFKGFYWNAVADVAWFPLTLVFLLDAV 
Opossum VAKCLFNGFYWNAAADVAWFPLTLVFLLDAV 
Chicken VAKCLVNGFYWSIAADVSWFPLTIVFLLDAV 
Stickleback VSVCLFSGFYWSKAADVAWFPLTLVFLLDAV 
3.2.16 Dnah11 has 3 missense and 3 nonsense mutations 
The first missense mutation in Dnah11 occurs in exon 33 at position 1878 (T1878A). The 
mutation is conserved across all species and is located in a highly conserved region so it is a 
damaging mutation. 
Table 18. Dnah11 missense mutation in exon 33 is damaging and located in a highly conserved 
region. 
 
Mouse 
3’-------------------------5’ 
MGLARGLDKTTETKGTGAPGAPAGSMTLHLS 
Rat MGLARGLDKTTETKGTGAPGAPAGSMTLHLS 
Human MGLARGLDKTTETKGTGAPGAPAGSMTLHLS 
Orangutan MGLARGLDKTTETKGTGAPGAPAGSMTLHLS 
Dog MGLARGLDKTTETKGTGAPGAPAGSMTLHLS 
Horse MGLARGLDKTTETKGTGAPGAPAGSMTLHLS 
Opossum MGLAHGLDKTTETKGTGAPGAPAGSMTLHLS 
Chicken IGLARGLDKTTETKGTGAPGAPAGSMTLHLS 
Stickleback VGLARGLDKTTETKGTGAPGAPAGSMTLHLA 
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The next missense mutation in Dnah11 occurs at the seventh amino acid in exon 41 at 
position 2214 (L2214R). It is conserved across all species except for the stickleback. If we look 
at the recovered mutation, the uncharged leucine is changed into a positively charged arginine. 
Since there is a change in charge, this mutation is considered possibly damaging. 
Table 19. Dnah11 missense mutation in exon 41 is possibly damaging. 
 
Mouse 
3’-----------------------5’ 
VIWTPGDHTLNAQERLISSFLG…intron 
Rat VIWTPGDHTLNAQERLISSLLG…intron 
Human VIWKPGDHKLNAQERLISSFLG…intron 
Orangutan VIWKPGDHKLNAQERLISSFLG…intron 
Dog IIWKPGDHKLNAQERLISSFLG…intron 
Horse VIWKPGDHMLNAQERLVSSFLG…intron 
Opossum VIWKPGSHLLNAQERLLSSFLG…intron 
Chicken VLWKPGEHMAKTQERLLL----…intron 
Stickleback VIWKPGVHSIAAQERMLSSLLG…intron 
 
The third missense mutation in Dnah11 is located in exon 64 at position 3457 (I3457F). 
The mutation is conserved across all species and is therefore a damaging mutation. 
Table 20. Dnah11 missense mutation in exon 64 is damaging. 
 
Mouse 
3’-------------------------5’ 
QQPDIMLPWRECHTLITANETSMRDSPLGEN 
Rat QQPDIMLPWRKCHTLITANETSMRDSPLGQN 
Human QQPDIVLPWRECHTLIAANETSMRDSPLGEN 
Orangutan QQPDIVLPWRECHTLIAANETSMRDSPLGEN 
Dog QQPDIMLPWRECHTLITANETSMRDNPLGEN 
Horse QQPDIMLPWRECHTLITANETSMRDNPLGEN 
Opossum QQPDIMLPWREAHTLITANETSMRDSPLGEN 
Chicken K*PDIMLPCHECHTLITAREASMQDGLLGRN 
Stickleback QQPDILLPWRESTTLISANETSMRDNPLGQN 
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The first nonsense mutation in Dnah11 is located at the fifth to last amino acid of exon 16 
at position 1062 (Q1062X). The mutation is conserved across all species, except for stickleback. 
This mutation inserts a stop codon very early in the gene, which will cause the coded protein to 
be dysfunctional.  
Table 21. Dnah11 nonsense mutation is located at the end of exon 16, which is not a highly 
conserved region. 
 
Mouse 
3’---------------------5’ 
Intron…QEKFQELTPPQLIDESAPAD 
Rat Intron…QEKFQELTPSQLIDEGAPAD 
Human Intron…QEKFQELTPPQPIEENAHAD 
Orangutan Intron…QEKFQELTPPQPIEENAHA- 
Dog Intron…QEKFQELTPPQPVEEYVHAD 
Horse Intron…QEKFQELTPPQPIEKNAHAD 
Opossum Intron…QEKFQEITPPQPLGENAQID 
Chicken Intron…QEKCQRTTPPWS--KDTFTD 
Stickleback Intron…QEKFNNITPPSLLADAGCAE 
 
 The next Dnah11 nonsense mutation is located in the second to last amino acid of exon 
60 at position 3279 (Y3279X). It is conserved in all species except for the chicken. The  
Table 22. Dnah11 nonsense mutation is located at the end of exon 60 in a fairly conserved 
region. 
 
Mouse 
3’------------------5’ 
Intron…EYFRIINIVWACLGAAA 
Rat Intron…EYFKIINIVWACLGAAA 
Human Intron…EYFKIINIVWACLGAAA 
Orangutan Intron…EYFKIINIVWACLGAAA 
Dog Intron…QYFKVINIVWACLGAAA 
Horse Intron…EYFKIINIVWACLGAAA 
Opossum Intron…EYFKVINIVWACLGAAA 
Chicken Intron…EHFRVINVVWSCLGAAA 
Stickleback Intron…EYYRVINITWACLGAAA 
 
 The final nonsense mutation in Dnah11 is located in the second to last amino acid of exon 
63 at position 3415 (Q3415X). This mutation is not highly conserved, as there are different wild 
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 type amino acids in both the dog and the horse. However, since it is a nonsense mutation that 
introduces an early stop codon it is considered a damaging mutation. 
Table 23. Dnah11 nonsense mutation is located at the end of exon 63 in a poorly conserved 
region. 
 
Mouse 
3’------------------5’ 
Intron…KQQLFPIWKCDVLEQRY 
Rat Intron…KQQLFPIWKCDVLEQRY 
Human Intron…KQQLFPVWKCHVLEQRY 
Orangutan Intron…KQQLFPVWKCHVLEQRY 
Dog Intron…KHQLFPVWKCDVLEQRY 
Horse Intron…KRQLFPVWKCDVLEQRY 
Opossum Intron…KQKLFPIWKCQVLEERY 
Chicken Intron…KQKLFPIWFR*IQEQ-- 
Stickleback Intron…KQRLFPIWENNLLQARY 
3.2.17 Dnah5 has 6 missense mutations 
Dnah5 has six different missense mutations. The first mutation is located at the sixth amino acid 
in exon 19 at position 919 (H919N). It is not conserved at all as the wild type amino acid in mice 
is only present in that species. Our mutation changes the wild type amino acid of a positively 
charged histidine to an uncharged asparagine. Asparagine is the wild type amino acid for the 
human and orangutan, therefore this mutation is considered tolerated because the mutated amino 
acid is present as the wild type amino acid for two species. 
Table 24. Dnah5 missense mutation is located at the beginning of exon 19 and is tolerated. 
 
Mouse 
5’---------------------3’ 
Intron…GRREGHSEALASFNAGASSL 
Rat Intron…GGGEGCAEALASFNAGTSSL 
Human Intron…EREEGNFDTLTSINARANAL 
Orangutan Intron…E--EGNFDTLTSINARADAL 
Dog Intron…E=-EGKSDTLTPLRAPAGLL 
Horse Intron…E=-EGISDTLTSLNAGAGLL 
Opossum Intron…==================== 
Chicken Intron…---ERRSKSLTSNNSWAGLS 
Stickleback Intron…---EGRLTTL-PCQCRPFL- 
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 The next missense mutation is located at the tenth amino acid in exon 34 at position 1835 
(W1835R). The amino acid is conserved across all species and is thus a damaging mutation.  
Table 25. Dnah5 missense mutation is located at the beginning of exon 34 and is damaging. 
 
Mouse 
5’--------------------------3’ 
Intron…VGLLGIQMLWTRDSEEALRNAKFDK 
Rat Intron…VGLLGIQMLWTRDSEEALQNAKFDK 
Human Intron…VGLLGIQMIWTRDSEEALRNAKFDK 
Orangutan Intron…VGLLGIQMIWTRDSEEALRNAKFDK 
Dog Intron…VGLLGIQMIWTRDSEEALRNAKYDK 
Horse Intron…VGLLGIQMIWTRDSEEALRNAKFDK 
Opossum Intron…VGLLGIQLIWTRDSEEALTNAKFDK 
Chicken Intron…VGLLGIQMIWTRDSEEALTNARYDK 
Stickleback Intron…VGLLGIQMIWTRDSEEALTNARYDR 
 
 The following Dnah5 mutation is located at the end of exon 48 at position 2657 
(N2657K). It is conserved across all species and thus is a damaging mutation. 
Table 26. Dnah5 missense mutation is located at the end of exon 48 and is damaging. 
 
Mouse 
5’---------------------------3’ 
GPPAGKKMAVFIDDLNMPVINEWGDQ…intron 
Rat GPPAGKKMAVFIDDLNMPVINEWGDQ…intron 
Human GPPAGKKMTVFIDDVNMPIINEWGDQ…intron 
Orangutan GPPAGKKMTVFIDDVNMPIINEWGDQ…intron 
Dog GPPAGKKMTIFIDDINMPIINEWGDQ…intron 
Horse GPPAGKKMTVFIDDVNMPIINEWGDQ…intron 
Opossum GPPAGKKMTVFIDDVNMPVINEWGDQ…intron 
Chicken GPPAGKKMTVFIDDVNMPIINEWGDQ…intron 
Stickleback GPPAGKKMSVFIDDINMPVINEWGDQ…intron 
 
 The next missense mutation is also considered damaging because it is conserved across 
all species. It is located at the end of exon 59 at position 3350 (S3350P). 
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 Table 27. Dnah5 missense mutation is located at the end of exon 59 and is damaging. 
 
Mouse 
5’-------------------------------3’ 
KIDVDKGCTMPSWQESLKLMTAGNFLQNLQ…intron 
Rat KIDLDKSCTVPSWQESLKLMTAGNFLQNLQ…intron 
Human KIDLEKSCTMPSWQESLKLMTAGNFLQNLQ…intron 
Orangutan KIDLEKSCTMPSWQESLKLMTAGNFLQNLQ…intron 
Dog KIDLEKSCTIPSWQESLKLMTAGNFLQNLQ…intron 
Horse KIDLEKSCTIPSWQESLKLMTAGNFLQNLQ…intron 
Opossum KIDLEKSCVIPSWQESLKLMTAGNFLQNLQ…intron 
Chicken KIDQEKSCTTPSWQESLKLMTAGNFLQNLQ…intron 
Stickleback KIDPEKNCNTPSWQESLKLMTAGNFMGSLQ…intron 
 
 The next Dnah5 mutation is located in exon 76 at position 4390(L4390P). It is conserved 
across all species and is located in a fairly conserved region. This mutation is also considered 
damaging. 
Table 28. Dnah5 missense mutation in exon 76 is damaging. 
 
Mouse 
5’-------------------------3’ 
ERLQKMGPFQPMNIFLRQEIDRMQRVLSLVR 
Rat ERLQKMGPFQPMNIFLRQEIDRMQRVLSLVR 
Human ERLQKMGPFQPMNIFLRQEIDRMQRVLSLVR 
Orangutan ERLQKMGPFQPMNIFLRQEIDRMQRVLSLVR 
Dog ERLQKMGPFQPMNIFLRQEIDRMQKLLSLVR 
Horse ERLQKMGPFQPMNIFLRQEIDRMQRVLTLVR 
Opossum DRLQKMGLFQPMNIFLRQEIDRMQRVISLVR 
Chicken EKLKNMGPFQPMNIFLRQEIQQMQRVISLVR 
Stickleback ERLQKMGPFQPMNIFLRQEIDRMQRVIVLVR 
 
 The final mutation in Dnah5 is located in exon 76 at position 4404 (S4404T) and is 
conserved throughout all species except for the stickleback. The wild type amino acid is an 
uncharged serine, which is then mutated into an uncharged threonine. Since there is no change in 
charge this mutation is possibly tolerated. 
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 Table 29. Dnah5 missense mutation in exon 76 is damaging. 
 
Mouse 
5’-----------------3’ 
FLRQEIDRMQRVLSLVRSTLTE 
Rat FLRQEIDRMQRVLSLVRSTLTE 
Human FLRQEIDRMQRVLSLVRSTLTE 
Orangutan FLRQEIDRMQRVLSLVRSTLTE 
Dog FLRQEIDRMQKLLSLVRSTLTE 
Horse FLRQEIDRMQRVLTLVRSTLTE 
Opossum FLRQEIDRMQRVISLVRSTLTE 
Chicken FLRQEIQQMQRVISLVRSTLTE 
Stickleback FLRQEIDRMQRVIVLVRNTLTE 
3.2.18 Dnaic1 missense mutation 
Dnaic1 contains one missense mutation, which is located at the third amino acid of the end of 
exon 16 at position 522 (I522T). The amino acid is conserved throughout all nine species. 
Table 30. Dnaic1 missense mutation is damaging and located at the end of exon 16 in a fairly 
conserved region. 
 
Mouse 
5’-------------------3’ 
KEIDYMFLVGTEEGKIYK…intron 
Rat KEIDYLFLVGTEEGKIYK…intron 
Human KEIDYMFLVGTEEGKIYK…intron 
Orangutan KEIDYMFLVGTEEGKIYK…intron 
Dog KEIDYMFLVGTEEGKIYK…intron 
Horse KEIDYMFLVGTEEGKIYK…intron 
Opossum KQIDYLFLVGTEEGKIYK…intron 
Chicken KKIDYLFLVGTEEGKIYK…intron 
Stickleback KQIDYLFLVGTGEGKIHK…intron 
3.2.19 Dync2h1 missense mutation 
The missense mutation in Dync2h1 is located in exon 5 at position 234 (V234E). It is conserved 
in all species except for the stickleback. The recovered mutation changes the wild type, 
uncharged, nonpolar valine into a negatively charged, polar glutamic acid. Since the mutation 
changes the charge and polarity, it is considered possibly damaging. 
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 Table 31. Dync2h1 missense mutation in exon 5 is possibly damaging. 
 
Mouse 
3’-------------------------5’ 
LMRSEPYHDHETQRWVDDVVDRTTEVLDVVE 
Rat LMRSEPYHDHETQRWVDDVVDRTTEVLDVVE 
Human LMRSEPYHDHETQRWVDDVVDQTTEVLDVVE 
Orangutan LMRSEPYHDHETQRWVDDVVDQTTEVLDVVE 
Dog LMRSEPYHDHETQRWVDDVVDRTTEVLDVVE 
Horse LMRSEPYHDYETQRWVDDVVDRTTEVLDVVE 
Opossum LMRAEPYHEHETQRWVDDVADRTTEVLDVVE 
Chicken RMRPQPFPDHETQRWVNDVTDRTTEVLDVVE 
Stickleback VMRTEPYPEYDTQRWTDDLADRSQEVLDMVD 
3.2.20 Dyx1c1 missense mutation 
The Dyx1c1 gene has one missense mutation located at the first amino acid in exon 1. It is 
conserved in almost all species except the opossum. The recovered mutation changes the 
uncharged, nonpolar methionine into a positively charged, polar lysine. This mutation is thus 
considered possibly damaging because of the change in charge and polarity. 
Table 32. Dyx1c1 missense mutation is located in the first amino acid of exon 1 and is possibly 
damaging. 
 
Mouse 
5’-----------------3’ 
Intron…MPVRVSEFSWQQTPAT 
Rat Intron…MPVRVSEFSWQQTPAA 
Human Intron…MPLQVSDYSWQQTKTA 
Orangutan Intron…MPLQVSDYSWQQTKTA 
Dog Intron…MPLLVSDYNWQQTKTA 
Horse Intron…MPLQVSDYSWQQTKVA 
Opossum Intron…TPLQIRDYSWQQTEST 
Chicken Intron…MPLWLREYSWRQSGAA 
Stickleback Intron…================ 
3.2.21 Foxj1 missense mutation 
Foxj1 has one missense mutation, which is located in exon 2 at position 142 (I142N). The wild 
type amino acid is conserved across all species and so the recovered mutation is damaging. 
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 Table 33. Foxj1 missense mutation in exon 2 is damaging.  
 
Mouse 
3’--------------------------5’ 
FYCFNDTIWKYIASLTIKTAKSAQMAMCILTA 
Rat  
Human FYCFNDTIWKYIASLTIKTAKSAQMAMCILTA 
Orangutan FYCFNDTIWKYIASLTIKTAKSAQMAMCILTA 
Dog FYCFNDTIWKYIASLTIKTAKSAQMAMCILTA 
Horse  
Opossum FYCFNDTIWKYIASLTIKTAKSAQMAMCILTA 
Chicken FYCFNDTIWKYIASLTIKTKKSAEMAMCILTA 
Stickleback YYCFNETIWKYICALTIKTKKSAQMAMCILTA 
3.2.22 Frem2 missense mutation 
The Frem2 mutation is located at the seventh to last amino acid in exon 11 at position 2292 
(Y2292C). It is conserved across all nine species and is thus a damaging mutation. It is also 
located in a fairly conserved region. 
Table 34. Frem2 missense mutation in exon 11 is damaging and located in a conserved region at 
the end of the exon. 
 
Mouse 
3’-----------------------5’ 
Intron…EESVPHYDEGSTASGDKTHVRV 
Rat Intron…EESVPHYDEGSTASGDKTHVRV 
Human Intron…EESVPHYDEGSTASGDKTHVRV 
Orangutan Intron…EESVPHYDEGSTASGDKTHVRV 
Dog Intron…EESVPHYDEGSTASGDKTHVRV 
Horse Intron…EESVPHYDEGSTASGDKTHVRV 
Opossum Intron…EESVPLYDEGSVASGDKTHVRV 
Chicken Intron…EESIPHYDEGSIASGDKTHVRV 
Stickleback Intron…EESIPHYDEGSTASGDKTHVRV 
3.2.23 Gm1060 has 2 missense mutations 
The Gm1060 missense mutation is conserved across all eight species even though the 
surrounding region is not highly conserved as you can see in Table 35. The mutation is located in 
exon 15 at position 674 (Y674C). 
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 Table 35. Gm1060 missense mutation in exon 15 is damaging.  
 
Mouse 
5’-------------------------3’ 
LKLKKETRDNSKDTEYWESLAAVIPFFKQNL 
Rat QRLKKDTRNNLKDTEYWESLAMVIPFSKQNL 
Human LRVQKNVRDNSKDSEYWQALTTVIPSSKQNL 
Orangutan LRVQKNVRDNSKDSEYWQALTTVIPSSKQNL 
Dog V--LKHVRDDSKDSEYWEALTTVISDTTQNL 
Horse VKLMKDVRDDSEDSEYWKALATVIPDATQNL 
Opossum VKVVREIRDTSKDSEYWTALCYIIPLQRQKL 
Chicken AKEVLQVRDSSKDGEYWEALAHVIPEPTLKL 
Stickleback  
 
The second missense mutation in Gm1060 is located only 12 nucleotides, or 4 amino 
acids, after the first missense mutation. It is also located in exon 15 at position 678 (L678Q). 
Similarly to the first missense mutation, the wild type amino acid is conserved across all eight 
species and is located in a poorly conserved region. 
Table 36. Gm1060 missense mutation in exon 15 is damaging.  
 
Mouse 
5’-------------------------3’ 
KETRDNSKDTEYWESLAAVIPFFKQNLWDAL 
Rat KDTRNNLKDTEYWESLAMVIPFSKQNLWDAL 
Human KNVRDNSKDSEYWQALTTVIPSSKQNLWDAL 
Orangutan KNVRDNSKDSEYWQALTTVIPSSKQNLWDAL 
Dog KHVRDDSKDSEYWEALTTVISDTTQNLWDAL 
Horse KDVRDDSEDSEYWKALATVIPDATQNLWDAL 
Opossum REIRDTSKDSEYWTALCYIIPLQRQKLWDAL 
Chicken LQVRDSSKDGEYWEALAHVIPEPTLKLWDAL 
Stickleback  
3.2.24 Hace1 missense mutation 
The Hace1 missense mutation is conserved across all nine species and is also located in a highly 
conserved region and the surrounding region is also highly conserved. The mutation occurs in 
the sixteenth amino acid of exon 19 at position 687 (Y687F). 
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 Table 37. Hace1 missense mutation in exon 19 is damaging and located at the beginning of the 
exon in a highly conserved region. 
 
Mouse 
5’--------------------------------3’ 
Intron…GIPVNYQDVASIDPEYAKNLQWILDNISDLG 
Rat Intron…GIPVNYQDVASIDPEYAKNLQWILDNISDLG 
Human Intron…GIPVNYQDVASIDPEYAKNLQWILDNISDLG 
Orangutan Intron…GIPVNYQDVASIDPEYAKNLQWILDNISDLG 
Dog Intron…GIPVNYQDVASIDPEYAKNLQWILDNISDLG 
Horse Intron…GIPVNYQDVASIDPEYAKNLQWILDNISDLG 
Opossum Intron…GIPVNYQDVASIDPEYAKNLQWILDNISDLG 
Chicken Intron…GIPVNYQDVASIDPEYAKNLQWILDNISDLG 
Stickleback Intron…GIPVNYQDVSSIDPEYAKNLQWILDNISDLG 
3.2.25 Hectd1 nonsense mutation 
Hectd1 nonsense mutation is located in the fourth amino acid of exon 22 at position 100 
(Y1088X). The mutation is conserved throughout all nine species and is also located in a highly 
conserved region. 
Table 38. Hectd1 nonsense mutation is located at the beginning of exon 22 in a highly conserved 
region. 
 
Mouse 
3’--------------------5’ 
STVVVLGYAAPNVWEYATK…intron 
Rat STVVVLGYAAPNVWEYATK…intron 
Human STVVVLGYAAPNVWEYATK…intron 
Orangutan STVVVLGYAAPNVWEYATK…intron 
Dog STVVVLGYAAPNVWEYATK…intron 
Horse STVVVLGYAAPNVWEYATK…intron 
Opossum STVVVLGYAAPNVWEYATK…intron 
Chicken STVVVLGYAAPNVWEYATK…intron 
Stickleback STVVVFGYAAPNVWEYATK…intron 
3.2.26 Hr nonsense mutation 
The Hr nonsense mutation is located at the end of exon 13 at position 911 (W911X). The 
mutation occurs in the ninth to last amino acid and introduces an early stop codon towards the 
end of the exon. It is conserved across all seven species, but is located in a poorly conserved 
region. 
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 Table 39. Hr nonsense mutation is located at the end of exon 13 in a poorly conserved region. 
 
Mouse 
5’-------------------------3’ 
ALGPPQPTNLDSTAFWEGFSHPET…intron 
Rat ALGPPQPTSLDSTAFWKGFSHPEA…intron 
Human PLGPPQPSSLGSTTFWEGFSWPEL…intron 
Orangutan PLGPPQPTSLDSTTFWEGFSWPEL…intron 
Dog PLGPPQPTSLRSATFWEGFSRPEI…intron 
Horse PLGPPQPTSLGSTAFWEGFSRPEV…intron 
Opossum LLGPPRPTDLSSTAFWKGFSRPEA…intron 
Chicken  
Stickleback  
3.2.27 Ift140 missense mutation 
Ift140 has a missense mutation that occurs at the sixth to last amino acid of exon 9 at position 
380 (N380D). The mutation is conserved across all species and is thus considered damaging. 
Table 40. Ift140 missense mutation in exon 9 is damaging.  
 
Mouse 
5’----------------------3’ 
GKDMWALQTPTELEGNITQIK…intron 
Rat GKDMWALQTPTELEGNITQIK…intron 
Human GKDRWALQTPTELQGNITQIQ…intron 
Orangutan GKDRWALQTPTELQGNITQIQ…intron 
Dog ============================ 
Horse GKDRWTLQTPTELEGNITQIK…intron 
Opossum GKDKWTLQTPTELEGNITQIK…intron 
Chicken GKEKWKLQASTELEGNITQIK…intron 
Stickleback AKAQWQLQTPTEVDGNVIQLQ…intron 
3.2.28 Ift74 missense mutation 
Ift74 missense mutation is located in the eight amino acid of exon 19 at position 549 (W549R), 
which is about half way into the exon. The mutation is conserved across all nine species and is 
also in a fairly conserved region therefore the mutation is damaging. 
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 Table 41. Ift74 missense mutation in exon19 is damaging.  
 
Mouse 
5’-----------------------------3’ 
Intron…LTNLERKWQHLEQNNFVMKEF…intron 
Rat Intron…LTNLERKWQHLEQNNFVMKEF…intron 
Human Intron…LTNLERKWQHLEQNNFAMKEF…intron 
Orangutan Intron…LTNLERKWQHLEQNNFAMKEF…intron 
Dog Intron…LTNLERKWQHHEQNNFVMKEF…intron 
Horse Intron…LTNLERKWQHHEQNNFVMKEF…intron 
Opossum Intron…LTNLERKWQHHEQNNFVMKEF…intron 
Chicken Intron…LTNLERKWQNLEQNNFMMKEF…intron 
Stickleback  
3.2.29 Kif7 missense mutation 
The Kif7 missense mutation is located in the tenth amino acid of exon 3 at position 186 (V186E). 
The mutation is located in a fairly conserved region within the exon that is also conserved across 
all species and considered damaging. 
Table 42. Kif7 missense mutation in exon 3 is damaging.  
 
Mouse 
3’--------------------------5’ 
ANGMELLSLVEDLGEVDVEKVGCLV…intron 
Rat ANGMELLSLVEDLGEVDVEKVGCLV…intron 
Human ANGMELLSLVEDLGEVDVEKVGCLV…intron 
Orangutan ANGMELLSLVEDLGEVDVEKVGCLV…intron 
Dog ANGMELLSLVEDLGEVDVEKVGCLV…intron 
Horse ANGMELLSLVEDLGEVDVEKVGCLV…intron 
Opossum ANGVELLSLVEDLGEVEVEKVGCLV…intron 
Chicken TNGMELLSLVEDLGEVESEKVGCLV…intron 
Stickleback TNGSELLSLVEDLGEVECEKVGFLV…intron 
3.2.30 Lox missense mutation 
The missense mutation in the Lox gene is located in the third to last amino acid at the end of 
exon 3 at position 285 (C285F). The amino acid is conserved across all species and is located in 
a highly conserved region. 
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 Table 43. Lox missense mutation at the end of exon 3 is in a highly conserved region and is 
damaging. 
 
Mouse 
3’-------------------5’ 
Intron…QHCSHWEWSYRPRSPLFD 
Rat Intron…QHCSHWEWSYRPRSPLFD 
Human Intron…QHCSHWEWSYRPRSPLFD 
Orangutan Intron…QHCSHWEWSYRPRSPLFD 
Dog Intron…QHCSHWEWSYRPRSPLFD 
Horse Intron…QHCSHWEWSYRPRSPLFD 
Opossum Intron…QHCSHWEWSYRPRSPLFD 
Chicken Intron…==============PLFD 
Stickleback Intron…QHCSHWEWSYRPRSPLFD 
3.2.31 Lrp1 missense mutation 
Lrp1 has one missense mutation, which is located in exon 82 at position 4232 (C4232R). The 
wild type amino acid is conserved across all species and is in a highly conserved region, with the 
exception of the stickleback species. This gene is not present in the chicken and there is not 
genetic information for the opossum. 
Table 44. Lrp1 missense mutation in exon 82 is damaging and located in a highly conserved 
region.  
 
Mouse 
3’--------------------------5’ 
CTGGNHCYEWCQDLECKDGTYRPQCRCKPQR 
Rat CTGGNHCYEWCQDLECKDGTYRPQCRCKPQR 
Human CTGGNRCHEWCQDLECKDGTYRPQCRCKPQR 
Orangutan CTGGNRCHEWCQDLECKDGTYRPQCRCKPQR 
Dog CTGGNRCYEWCQDLECKDGTYRPQCRCKPQR 
Horse CTGGNRCHEWCQDLECKDGTYRPQCRCKPQR 
Opossum =============================== 
Chicken  
Stickleback CTGGNKCYDRCLDIQCRDGGYNPQCHCKPQK 
3.2.32 Ltbp1 nonsense mutation 
Ltbp1 has a nonsense mutation located in exon 7 at position 378 (C378X). The amino acid at this 
position is conserved across all nine species, so the mutation is considered damaging. It is also 
located in a fairly conserved region of the exon. 
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 Table 45. Ltbp1 missense mutation in exon 7 is damaging.  
 
Mouse 
5’-------------------------3’ 
CMHPLSVHLTKQICCCSVGKAWGPHCEKCPL 
Rat CMHPLSVHLTKQICCCSVGKAWGPQCEKCPL 
Human CMHPLSVHLTKQLCCCSVGKAWGPHCEKCPL 
Orangutan CMHPLSVHLTKQLCCCSVGKAWGPHCEKCPL 
Dog CMHPLSVHLTKQLCCCSVGKAWGPHCEKCPL 
Horse CMHPLSVHLTKQLCCCSVGKAWGPHCEKCPL 
Opossum CMHPLSVQLSKQLCCCSVGKAWGPHCEKCPL 
Chicken CMHPLSVQLSKQLCCCSVGKAWGPNCEKCPL 
Stickleback CLHPVSTMLSKQLCCCSVGKAWGPRCDKCPP 
3.2.33 Megf8 has 2 missense mutations 
The first Megf8 missense mutation is located in exon 3 at position 148 (N148D). The amino acid 
at this position is not conserved across all species. The wild type amino acid that is present in 
mice is only present in rats also. The wild type amino acid is an uncharged, polar asparagine, 
which is changed into a negatively charged, polar aspartic acid. Since there is a change in charge, 
this mutation is considered possibly damaging. 
Table 46. Megf8 missense mutation in exon 3 is possibly damaging.  
 
Mouse 
5’-------------------------3’ 
FNASFRFSLCPGGCQNHGQCKSPGVCVCEPG 
Rat FNASFRFSLCPGGCQNHGQCKSPGVCVCEPG 
Human FNASFRFSLCPGGCQSHGQCQPPGVCACEPG 
Orangutan FNASFRFSLCPGGCRSHGQCQPPGVCACEPG 
Dog FNASYRFTLCPGGCSGHGQCQAPGVCTCEPG 
Horse FNASFRFSLCPGGCRSHGQCRPPGVCACEPG 
Opossum FNASFSFSLCPGGCSGRGLCEPSGLCTCDPG 
Chicken  
Stickleback FNATYTFSACPGACGGHGRCDPSTSCLCHQG 
 
 The second missense mutation in Megf8 is located in exon 21 at position 1214 (N1214I). 
This wild type amino acid is conserved across all species and is therefore considered damaging. 
It is also located in a fairly conserved region in the exon. 
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 Table 47. Megf8 missense mutation in exon 21 is damaging.  
 
Mouse 
5’-------------------------3’ 
FGNATGSGGCRPCQCNGHGDPRRGHCDNLTG 
Rat FGNATGSGGCRPCQCNGHGDPRRGHCDNLSG 
Human FGNATGSRGCRPCQCNGHGDPRRGHCDNLTG 
Orangutan FGNATGSRGCRPCQCNGHGDPRRGHCDNLTG 
Dog FGNATGSGGCRPCQCNGHGDPRRGHCDNLSG 
Horse FGNATGSGGCRPCQCNGHGDTRRGHCDNLSG 
Opossum FGNATGPGGCQPCQCNGHGDPQQGHCDGHTG 
Chicken  
Stickleback FGSALGGGGCVQCECNGHGDPARGYCHNQTG 
3.2.34 Mical1 missense mutation 
The Mical1 missense mutation is located at the end of exon 22 at position 929 (M929T). The 
amino acid is not conserved across all species. The wild type amino acid is a nonpolar, 
hydrophobic methionine, which is then changed into a polar, uncharged threonine. Since there is 
a change in polarity, this mutation is considered possibly damaging. 
Table 48. Mical1 missense mutation is located at the end of exon 22 and is possibly damaging. 
 
Mouse 
5’--------------------3’ 
LEEKQRQLDHELRGYMNRE…intron 
Rat LEEKQRQLDHEFRG-INRE…intron 
Human LEEKQWQLDQELRGYMNRE…intron 
Orangutan LEEKQWQLDQELRGYMNQE…intron 
Dog LEEKQWHLDQELRGYLNQE…intron 
Horse LEEKQWQLDQELRGYMNRE…intron 
Opossum LEEKQWQLDQELRSYMDRK…intron 
Chicken LEEQQWQLDQELRWYIETE…intron 
Stickleback LEDKQSMLELELRKYMELN…intron 
3.2.35 Mmp21 missense mutation 
The missense mutation in Mmp21 is located in exon 2 at position 177 (W177L) and the wild 
type amino acid is not conserved across all species. At this position, the wild type amino acid is 
an uncharged, nonpolar tryptophan, which changes into a similarly uncharged, nonpolar leucine. 
Due to the lack of change in charge and polarity in this mutation it is considered possibly 
tolerated. 
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 Table 49. Mmp21 missense mutation in exon 2 is possibly tolerated. 
 
Mouse 
3’-------------------------5’ 
EDGSLQSSYADGVLRWTLTKKSFARSAGTDS 
Rat EDGSLQSSYADGVLRWTLTKKSFVRSAGTDS 
Human DAVSLQSSLAEGLLRWSLTRKSFAQAAGGDP 
Orangutan EAASLQSSLAEGLLRWSLTKKSFAQAAGGDP 
Dog EAEALQGSAGERLLRWSLTRKAFARPAGTPA 
Horse EDLALQSSVGEGLLRRTLPRKSFARPGGAPP 
Opossum EDIPLQSSYGEGMLRWRLLKRSFAQPAG--E 
Chicken =============================== 
Stickleback EEVSLQSSYGEGILRWKLVRKTFAM-VPTG* 
3.2.36 Nek8 missense mutation 
The Nek8 missense mutation is located in exon 3 at position 124 (I124T). The wild type amino 
acid is conserved across all species and is also located in a highly conserved region. This 
mutation is considered damaging. 
Table 50. Nek8 missense mutation in exon 3 is damaging. 
 
Mouse 
3’-------------------------5’ 
HKDLLINQTKLDRHLILHTHVHHLALLIQVF 
Rat HKDLLINQTKLDRHLILHTHVHHLALLIQVF 
Human HKDLLINQTKLDRHLILHTHVHHLALLIQVF 
Orangutan HKDLLINQTKLDRHLILHTHVHHLALLIQVF 
Dog HKDLLINQTKLDRHLILHTHVHHLALLIQVF 
Horse HKDLLINQTKLDRHLILHTHVHHLALLIQVF 
Opossum QKDLLINQTKLDRHLILHSHVHHLALLIQVF 
Chicken HKDLLINQTKLDRHLIQKTHVHHLALLIQVF 
Stickleback HKDLLINQTKLDRHLILKNHVHYLALLIQVF 
3.2.37 Pcsk5 has 2 missense mutations 
The first mutation in Pcsk5 is located at the beginning of exon 4 at position 174 (D174G). The 
amino acid is conserved across al nine species and is therefore damaging. 
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 Table 51. Pcsk5 missense mutation in exon 4 is damaging. 
 
Mouse 
3’------------------------------5’ 
Intron…YNQMLDPHTREIGDDLITVVINKGTYGRK 
Rat Intron…YNQMLDPHTREIGDDLITVVINKGTYGRK 
Human Intron…YNQMLDPHTREIGDDLITVVINKGTYGRK 
Orangutan Intron…YNQMLDPHTREIGDDLITVVINKGTYGRK 
Dog Intron…YNQMLDPHTREIGDDLITVVINKGTYGRK 
Horse Intron…YNQMLDPHTREIGDDLITVVINKGTYGRK 
Opossum Intron…YNKVLDPHTREIGDDLITVVVDRGTYGRK 
Chicken Intron…YNQMLDPHNREIGDDLITVVVNKGTYGRK 
Stickleback Intron…YNQFLDPHNREIGDDLITVVVDKGTYGRK 
 
 The second missense mutation in Pcsk5 is located in exon 35 at position 1599 (C1599S). 
The mutation is conserved across all nine species and is therefore damaging. 
Table 52. Pcsk5 missense mutation in exon 35 is damaging. 
 
Mouse 
3’-------------------------5’ 
DCSQCDTPRPGRCSKCSKDCKECRGSTSEGY 
Rat DCSQCDTPQPGRCTKCSKDCKECRGSTSEGY 
Human DCSLCDTPRPGQCGKCSRNCRECRGTSNDAY 
Orangutan DCSLCDTPRPGQCGKCSRNCRECRGTSNDAY 
Dog DCSLCDAPGPGQCAKCSKSCRECRGTSIEAY 
Horse DCSLCDTPRPGRCAKCSRNCRECRGTANEAY 
Opossum HCSLCNTSHPGWCKRCDQNCKECLGSSNNAY 
Chicken DCFLCDTPQPGMCEKCGKHCHECSGTSNQAF 
Stickleback RCSLCNKNGPGWCRSCAPDCRECVMTNTNGF 
3.2.38 Pde2a missense mutation 
The Pde2a missense mutation is located in the middle of exon 23 at the thirteenth amino acid at 
position 682 (M682R). The mutation is located in a highly conserved region where it is 
conserved across all species and thus is a damaging mutation. 
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 Table 53. Pde2a missense mutation in exon 23 is damaging. 
 
Mouse 
5’---------------------------------------3’ 
Intron…EDIEIFALFISCMCHDLDHRGTNNSFQVAS…intron 
Rat Intron…EDIEIFALFISCMCHDLDHRGTNNSFQVAS…intron 
Human Intron…EDIEIFALFISCMCHDLDHRGTNNSFQVAS…intron 
Orangutan Intron…EDIEIFALFISCMCHDLDHRGTNNSFQVAS…intron 
Dog Intron…EDIEIFALFISCMCHDLDHRGTNNSFQVAS…intron 
Horse Intron…EDIEIFALFISCMCHDLDHRGTNNSFQVAS…intron 
Opossum Intron…DDIEIFALFVSCMCHDLDHRGTNNSFQVAS…intron 
Chicken  
Stickleback Intron…EEIEILALFVSCMCHDLDHRGTNNSFQVAS…intron 
3.2.39 Pkd1 missense mutation 
Pkd1 contains a missense mutation that is located at the end of exon 38 at position 3695 
(I3695N). The mutation is conserved across all species and is thus a damaging mutation. 
Table 54. Pkd1 missense mutation in exon 38 is damaging. 
 
Mouse 
5’-------------------------------3’ 
GDASCHGHAYRLQSAIKQELDSQAFLAITR…intron 
Rat GDASCHGHAYRLQSAIKQELDSQAFLAITR…intron 
Human GDASCHGHAYRLQSAIKQELHSRAFLAITR…intron 
Orangutan GDASCHGHAYRLQSAIKQELHSRAFLAITR…intron 
Dog GDASCHNHAYRLQSAIKQELGSQAFLAITR…intron 
Horse GDASCHSHAYRLQSAIKQELDSQAFLAITR…intron 
Opossum GDASSHTHAYRLQSSIKQELDSKAFLGITR…intron 
Chicken GDATRNSRAFLLQSSIKQQLGSSEFLHIKR…intron 
Stickleback ============================== 
3.2.40 Plxnd1 missense mutation 
The Plxnd1 missense mutation is located in a highly conserved region of exon 27 at position 
1576 (D1576G). The mutation is conserved across all species except for the stickleback species. 
The wild type amino acid at this position is a polar, negatively charged aspartic acid. The 
mutation changes this into a nonpolar, uncharged glycine. Since there is a change in charge and 
polarity, the mutation is considered possibly damaging. 
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 Table 55. Plxnd1 missense mutation in exon 27 is possibly damaging. 
 
Mouse 
3’-------------------------5’ 
FAELIKEKVQTLTDTDMARVSLSDMGCGQFS 
Rat FAELIKEKVQTLTDTDMARVSLSDMGCGQFS 
Human FAELIKEKVQTLTDTDMARVSLSDMGCGQFS 
Orangutan FAELIKEKVQTLTDTDMARVSLSDMGCGQFS 
Dog FAELIKEKVQTLTDTDMARVSLSDMGCGQFS 
Horse FAELIKEKVQTLTDTDMARVSLSDMGCGQFS 
Opossum FAELIKEKVQTLTDTDMARVSLSDMGCGQFS 
Chicken FAELIKEKVQSLTDTDMARVSLSDMGCGQFS 
Stickleback FAELIKEKVQCVTDTNMVRVPLSDMGCGQFS 
3.2.41 Prickle1 missense mutation 
The Prickle1 missense mutation is located in exon 5 at position 161 (C161F). The mutation is 
located in a highly conserved region and is also conserved across all nine species, making it a 
damaging mutation. 
Table 56. Prickle1 missense mutation in exon 5 is damaging. 
 
Mouse 
3’-------------------------5’ 
KGDQYFYILDVLLENCTFCVFCSPHWCVGPG 
Rat KGDQYFYILDVLLENCTFCVFCSPHWCVGPG 
Human KGDQYFYILDVLLENCTFCVFCSPHWCVGPG 
Orangutan KGDQYFYILDVLLENCTFCVFCSPHWCVGPG 
Dog KGDQYFYILDVLLENCTFCVFCSPHWCVGPG 
Horse KGDQYFYILDVLLENCTFCVFCSPHWCIGPG 
Opossum KGDQYFYILDVLLENCTFCVFCAPHWWIGPG 
Chicken KGDQYFYILDVLLENCTFCVFCSPHWCVGPG 
Stickleback KGNQYFYILDVLLEQCTTCVFCAPHWCPGLG 
3.2.42 Pskh1 missense mutation 
Pskh1 contains one missense mutation located in exon 2 at position 219 (L219P). The mutation 
is considered damaging because the wild type amino acid is conserved across all species and it is 
also in a highly conserved region. 
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 Table 57. Pskh1 missense mutation in exon 2 is damaging.  
 
Mouse 
5’-------------------------3’ 
DGVRYLHALGITHRDLKPENLLYYHPGTDSK 
Rat DGVRYLHALGITHRDLKPENLLYYHPGTDSK 
Human DGVRYLHALGITHRDLKPENLLYYHPGTDSK 
Orangutan DGVRYLHALGITHRDLKPENLLYYHPGTDSK 
Dog DGVRYLHALGITHRDLKPENLLYYHPGTDSK 
Horse DGVRYLHALGITHRDLKPENLLYYHPGTDSK 
Opossum DGVKYLHTLGITHRDLKPENLLYYHPGTDSK 
Chicken DGVRYLHTLGITHRDLKPENLLYYHPGTDSK 
Stickleback DGVKYLHTLGITHRDLKPENLLYYHPGSDSK 
3.2.43 Psme4 missense mutation 
The Psme4 mutation is located at the end of exon 28 at position 1083 (I1083V). The mutation is 
in a highly conserved region and is also conserved across all species so we may call it damaging. 
Table 58. Psme4 missense mutation in exon 28 is damaging. 
 
Mouse 
5’-----------------------------3’ 
EKPSIVRLFDDLAEKIHRQYETIGLDFT…intron 
Rat EKPSIVRLFDDLAEKIHRQYETIGLDFT…intron 
Human EKPSIVRLFDDLAEKIHRQYETIGLDFT…intron 
Orangutan EKPSIVRLFDDLAEKIHRQYETIGLDFT…intron 
Dog EKPSIVRLFDDLAEKIHRQYETIGLDFA…intron 
Horse EKPSIVRLFDDLAEKIHRQYETIGLDFT…intron 
Opossum EKPSIVRLFDDLAEKIHRQYETIGLDFT…intron 
Chicken EKPSIVRLFDDLAEKIHRQYETIGLDFA…intron 
Stickleback EKPSIVRLFDDLADKIHRQYETIGVDFS…intron 
3.2.44 Robo1 missense mutation 
Robo1 missense mutation is located in the fourth amino acid of exon 6 at position 270 (I270T). 
The amino acid is conserved across all species so we can call it a damaging mutation. 
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 Table 59. Robo1 missense mutation in exon 6 is damaging. 
 
Mouse 
5’--------------------3’ 
Intron…RYEIRDDHTLKIRKVTAGD 
Rat Intron…RYEIRDDHTLKIRKVTAGD 
Human Intron…RYEIRDDHTLKIRKVTAGD 
Orangutan Intron…RYEIRDDHTLKIRKVTAGD 
Dog Intron…RYEIRDDHTLKIRKVMAGD 
Horse Intron…RYEIRDDHTLKIRKVMAGD 
Opossum Intron…RYEIRDDHTLKIRKVMAGD 
Chicken Intron…RYEIRDDHTLKIRKVMAGD 
Stickleback Intron…RYEIREDHTLKIRRLTSAD 
3.2.45 Sema6a missense mutation 
The Sema6a missense mutation is located in a highly conserved region in exon 10 at position 275 
(S275P). The wild type amino acid is conserved across all species and is considered damaging. 
Table 60. Sema6a missense mutation in exon 10 is damaging.  
 
Mouse 
3’-------------------------5’ 
HSDGPVSCNLRAKLFSTWQKELVRQSGGMDN 
Rat HSDGPVSCNLRAKLFSTWQKELVRQSGGMDN 
Human HSDGPVSCNLRAKLFSTWQKELVRQSGGMDN 
Orangutan HSDGPVSCNLRAKLFSTWQKELVRQSGGMDN 
Dog HSDGPVSCNLRAKLFSTWQKELVRQSGGMDN 
Horse HSDGPVSCNLRAKLFSTWQKELVRQSGGMDN 
Opossum HSDGPVSCNLRAKLFSTWQKELVRQSGGMDN 
Chicken HSDGPVSCNLRAKLFSTWQKELVRQSGGMDN 
Stickleback HSDGPISCNLRSKLFSTWQKELVRPSGGRDN 
3.2.46 Smad6 nonsense mutation 
The Smad6 nonsense mutation is located in the tenth amino acid of exon 4 at position 328 
(K328X). It is conserved across all nine species and is also located in a highly conserved region 
so the mutation is damaging. 
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 Table 61. Smad6 nonsense mutation is located in a highly conserved region at the beginning of 
exon 4. 
 
Mouse 
3’--------------------------5’ 
RTRHEWYAVSCWHSPKTADPSMSAD…intron 
Rat RTRHEWYAVSCWHSPKTADPSMSAD…intron 
Human RTRHEWYAVSCWHSPKTADPSMSAD…intron 
Orangutan RTRHEWYAVSCWHSPKTADPSMSAD…intron 
Dog RTRHEWYAVSCWHSPKTADPSMSAD…intron 
Horse RTRHEWYAVSCWHSPKTADPSMSAD…intron 
Opossum RTRHEWYAVNCWHSQKMTDPSMSAD…intron 
Chicken RTRHEWYAVNCWHSRKVADPSTSAD…intron 
Stickleback RTRHEWYAVNCWHSQKPADPSMSAD…intron 
3.2.47 Smarca4 has 2 missense mutations 
The first Smarca4 missense mutation is located in the second amino acid of exon 8 at position 
417 (R417C). The amino acid at this position is conserved across all species and can therefore be 
called a damaging mutation. 
Table 62. Smarca4 missense mutation at the beginning of exon 8 is damaging. 
 
Mouse 
5’------------------3’ 
Intron…LRQEVVVCMRRDTALET 
Rat Intron…LRQEVVVCMRRDTALET 
Human Intron…LRQEVVVCMRRDTALET 
Orangutan Intron…LRQEVVVCMRRDTALET 
Dog Intron…LRQEVVVCMRRDTALET 
Horse Intron…LRQEVVVCMRRDTALET 
Opossum Intron…LRQEVVVCMRRDTALET 
Chicken Intron…LRQEVVACMRRDTTLET 
Stickleback Intron…LRQEVVVCMRRDTALET 
 
 The second missense mutation in Smarca4 is located in a highly conserved region within 
exon 16 at position 794 (T794I). The wild type amino acid is conserved across all species and is 
a damaging mutation. 
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 Table 63. Smarca4 missense mutation in exon 16 is damaging. 
 
Mouse 
5’-------------------------3’ 
DEMGLGKTIQTIALITYLMEHKRINGPFLII 
Rat DEMGLGKTIQTIALITYLMEHKRINGPFLII 
Human DEMGLGKTIQTIALITYLMEHKRINGPFLII 
Orangutan DEMGLGKTIQTIALITYLMEHKRINGPFLII 
Dog DEMGLGKTIQTIALITYLMEHKRINGPFLII 
Horse DEMGLGKTIQTIALITYLMEHKRINGPFLII 
Opossum DEMGLGKTIQTIALITYLMEHKRINGPFLII 
Chicken DEMGLGKTIQTIALITYLMEHKRLNGPYLII 
Stickleback DEMGLGKTIQTIALITYLMEYKRLNGPFLII 
3.2.48 Snx17 missense mutation 
The Snx17 missense mutation is located in the last amino acid of exon 5 at position 144 
(E144G). The mutation is located in a fairly conserved region and is conserved across all species 
except for the stickleback. The wild type amino acid at this position is a negatively charged, 
polar glutamic acid. The mutated amino acid is an uncharged, nonpolar glycine. Since there is a 
change in charge and polarity, the mutation is possibly damaging. 
Table 64. Snx17 missense mutation at the end of exon 5 is possibly damaging. 
 
Mouse 
5’------------------3’ 
VLVTVLTSDQTEDVLE…intron 
Rat  
Human VLVNVLTSDQTEDVLE…intron 
Orangutan VLVNVLTSDQTEDVLE…intron 
Dog VLVNVLTSDQTEDVLE…intron 
Horse VLVSVLTSDQTEDVLE…intron 
Opossum VLVTILTSDQTEDVLE…intron 
Chicken VKVTILTSDQTEDVLE…intron 
Stickleback VTVNILTSDQTEDVLD…intron 
3.2.49 Spata5 missense mutation 
Spata5 has a missense mutation, which is located in the thirteenth amino acid of exon 9 at 
position 498 (T498I). The wild type amino acid is conserved across all species, so it is a 
damaging mutation. 
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 Table 65. Spata5 missense mutation at the beginning of exon 9 is damaging. 
 
Mouse 
5’-----------------------------3’ 
Intron…EGSEGRVLVLGATNRPQALDAALRRPGR 
Rat Intron…EGSEGRVLVLGATNRPQALDAALRRPGR 
Human Intron…EVSEGQVLVLGATNRPHALDAALRRPGR 
Orangutan Intron…EVSEGQVLVLGATNRPHALDAALRRPGR 
Dog Intron…EGSEGQVLVLGATNRPHALDAALRRPGR 
Horse Intron…EGSEGQVLVLGATNRPHALDAALRRPGR 
Opossum Intron…EGSEGRVLVIGATNRLHSLDPALRRPGR 
Chicken Intron…EGSEGQLVVLGATNRPHALDAALRRPGR 
Stickleback Intron…EGMSGQLLVLGATNRPHALDPALRRPGR 
3.2.50 Sufu missense mutation 
Sufu missense mutation is located in a highly conserved region within exon 4 at position 177 
(M177K). The amino acid is conserved across all species so it is considered damaging. 
Table 66. Sufu missense mutation in exon 4 is damaging. 
 
Mouse 
5’-------------------------3’ 
SWHSPLDNSESRIQHMLLTEDPQMQPVRTPF 
Rat SWHSPLDNSESRIQHMLLTEDPQMQPVQTPF 
Human SWHSPLDNSESRIQHMLLTEDPQMQPVQTPF 
Orangutan SWHSPLDNSESRIQHMLLTEDPQMQPVQTPF 
Dog SWHSPLDNSESRIQHMLLTEDPQMQPVQTPF 
Horse SWHSPLDNSESRIQHMLLTEDPQMQPVQTPF 
Opossum SWHSPLDNSESRIQHMLLTEDPQMQPVQTPF 
Chicken SWHSPLDNSESRIQHMLLTEDPQMQPVQTPF 
Stickleback SWHSPLDNSESRIQHMLLTEDPQMQPVQTPF 
3.2.51 Tab1 missense mutation 
The Tab1 missense mutation is located in a highly conserved region within exon 9. It is the fifth 
amino acid within this exon and is located at position 312 (M312K). The amino acid is 
conserved across all species and is thus considered damaging. 
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 Table 67. Tab1 missense mutation at the beginning of exon 9 is damaging. 
 
Mouse 
5’---------------------3’ 
Intron…EIAAMIDTEFAKQTSLDAVA 
Rat Intron…EVAAMIDTEFAKQTSLDAVA 
Human Intron…EIAAMIDTEFAKQTSLDAVA 
Orangutan Intron…EIAAMIDTEFAKQTSLDAVA 
Dog Intron…EIAAMIDTEFAKQTSLDAVA 
Horse Intron…EIAAMIDTEFAKQTSLDSVA 
Opossum Intron…EIAAMIDTEFAKQTSLDAVA 
Chicken Intron…EIAAMIATEFAKQTSLDAVA 
Stickleback  
3.2.52 Tmem67 missense mutation 
The Tmem67 missense mutation is located in the thirteenth amino acid at the beginning of exon 
11 at position 374 (Y374N). The amino acid at this position is conserved in all species except for 
the stickleback. The wild type amino acid is an uncharged, nonpolar tyrosine, which is changed 
into an uncharged, polar asparagine. Since there is no change in charge with this mutation it is 
considered possibly tolerated. 
Table 68. Tmem67 missense mutation at the beginning of exon 11 is possibly tolerated. 
 
Mouse 
3’------------------------------5’ 
Intron…NQQYTTGFAYAADLRRETDPCL…intron 
Rat Intron…NQQYTTGFSYAADLRRETDPCL…intron 
Human Intron…NQQYTTGFSYAANLRTETDPCL…intron 
Orangutan Intron…NQQYTTGFSYAANLRTETDPCL…intron 
Dog Intron…NQQYTTGFSYAANLRTETDPCL…intron 
Horse Intron…NQQYTTGFSYAANLRTETDPCL…intron 
Opossum Intron…NQQYTTGFDYAADLRSVTDPCL…intron 
Chicken Intron…SQEYTTGFVYAANLKTQTDPCL…intron 
Stickleback Intron…SEQYATGFNFAAAQKSTTEPCL…intron 
3.2.53 Tpbpa missense mutation 
The Tpbpa gene is only present in a select few of the species in our set list. These species include 
the mouse, rat, human, orangutan, and horse. The wild type amino acid for the mouse is different 
than the wild type amino acid for all the other species. Our recovered mutation is located in exon 
3 at position 54 (S54R). This region is poorly conserved, as is the wild type amino acid. The 
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 recovered mutation shows us that the uncharged, polar serine is changed into a positively 
charged, polar arginine, meaning that the mutation is possibly damaging despite being in a 
poorly conserved region. 
Table 69. Tpbpa missense mutation in exon 3 is possibly damaging. 
 
Mouse 
3’--------------------------5’ 
SMEINSGETEQDNESSHLKNTKMFKSWVAKI 
Rat SMEIDLEEEEQDSKSNYLKVTKMFEDWVAKR 
Human NMAMTFSHKGERYEQNHQEIMKMNQ-WVARR 
Orangutan NMAMAFSHKGERYEQNHLEIMKMNKEWVARR 
Dog  
Horse NMAMTFGHKGQSYEQNHLEIMRMNKEWVARR 
Opossum  
Chicken  
Stickleback  
3.2.54 Wdr69 has 1 missense and 1 nonsense mutation 
The Wdr69 nonsense mutation is located at the beginning of exon 2 at position 19 (Y19X). The 
mutation is damaging because the amino acid is conserved across all species. This mutation 
introduces a stop codon very early in exon 2 and is therefore a damaging mutation. 
Table 70. Wdr69 nonsense mutation is at the beginning of exon 2 in a fairly conserved region. 
 
Mouse 
5’----------------------3’ 
Intron…GIMLEYEKGGELKTKSIDLLE 
Rat Intron…GIMLEYEKGGELKTKSIDLLE 
Human Intron…GIMLEYEKHGELKTKSIDLLD 
Orangutan Intron…GIMLEYEKHGELKTKSIDLLD 
Dog Intron…GIMLEYEKSGELKTKSIDLLN 
Horse Intron…GIMLEYEKSGELKTKSIDLLD 
Opossum Intron…GIILEYEKSGELKTKSIDLLD 
Chicken Intron… IILEYVEGGELKTRSIDLLD 
Stickleback Intron… IILEYEKEGLLKTKSMDLLD 
 
 The missense mutation in Wdr69 is located in exon 3 at position 66 (L66P). The amino 
acid at this position is conserved in all species except for the orangutan. If we analyze this 
mutation further, the amino acid changes from a leucine to a proline both of which are 
uncharged. Since there is no change in charge, this mutation is possibly tolerated. 
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 Table 71. Wdr69 missense mutation in exon 3 is possibly damaging.  
 
Mouse 
5’-------------------------3’ 
AEPLITASRTKQVRLLVQRLQEKLRQHSDHN 
Rat VEPLITASRTKQVRLLVQRLQEKLRQHCDHN 
Human AEPLLTASRTEQVKLLIQRLQEKLGQNSNHT 
Orangutan AEPLLTASRTEQVKLFIQRLQEKLGQHSNHT 
Dog AEPLITASRSEQVKLLIQRLQDKLRQHSNHT 
Horse AEPLITASRKDQVKLLIQRLQDKLGQHSNHK 
Opossum AEPLITASRTDQVKHLILKLQDKLGQQGDHK 
Chicken EEPLITASCKEHVIRLVQRLQEKLGEKEDHK 
Stickleback SEPLVTESRADQVKQLILRLQQKQGQKDQFG 
3.2.55 Xpnpep1 missense mutation 
The Xpnpep1 missense mutation is located at the end of exon 15 at position 416 (S4196P). The 
mutation is located in a fairly conserved region and the wild type amino acid is conserved across 
all nine species making this a damaging mutation. 
Table 72. Xpnpep1 missense mutation at the end of exon 15 is damaging. 
 
Mouse 
3’---------------------------------5’ 
Intron…KYQAGSDILYVEDLSLTRNTEPVPA…intron 
Rat Intron…KYQAGSDILYVEDLSLTRNTEPIPA…intron 
Human Intron…KYQAGSDILYVEDLSLTRNTEPVPA…intron 
Orangutan Intron…KYQAGSDILYVEDLSLTRNTEPVPA…intron 
Dog Intron…KYQAGSDILYVEDLSLTRNTEPVPA…intron 
Horse Intron…KYQAGSDILYVEDLSLTRNTEPVPA…intron 
Opossum Intron…KYQAGSDILYVENLSLMRNTEPVPS…intron 
Chicken Intron…KYQAGSDLLYIENVSLTRNTEPVPK…intron 
Stickleback Intron…VYQAGSDILYVENVSLTRNTEPLPR…intron 
3.2.56 Zfp161 nonsense mutation 
The Zfp161 nonsense mutation is located in a somewhat conserved region within exon 3 at 
position 140 (S140X). The mutation introduces an early stop codon in this exon, which is the 
reason why this mutation is damaging. It is damaging despite the fact that the wild type amino 
acid is not conserved in all species. 
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 Table 73. Zfp161 nonsense mutation in exon 3 is damaging.  
 
Mouse 
5’--------------------------3’ 
SQKRDVSSPDESNGQSKSKYCLKLNRPIGDA 
Rat SQKRDVSSPDESNGQSKSKYCLKLNRPIGDA 
Human SQKRDVSSPDENNGQSKSKYCLKINRPIGDA 
Orangutan SQKRDVSSPDENNGQSKSKYCLKINRPIGDA 
Dog SQKRDVSSPDENNGQSKSKYCLKINRPIGDA 
Horse SQKRDVSSPDENNGQSKSKYCLKINRPIGDA 
Opossum SQKRDVSSPEENNTQAKNKYCLKINRPIGES 
Chicken SQKRDVSS--EENTQSKSKYCLKINRPIGEP 
Stickleback TQKRELTN--EDAGEP--------------- 
3.3 DISEASE-CAUSING GENES 
There are a total of 62 disease-causing mutations that we were able to recover from the ENU 
screen. These genes all have varying functions that are involved in several different biological 
processes that may or may not contribute to cardiac development. Figure 4 shows the 
chromosomal location of each of the 62 disease-causing genes that we recovered from our 
screen.  
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Figure 4. Chromosomal location of 65 disease-causing genes detected in ENU mice. 
  
Figure 5 shows the number of disease causing homozygous mutations on each mouse 
chromosome. There are no mutations present on the sex chromosomes. This makes sense 
because any mutations on the X or Y chromosomes would result in a mutant phenotype in the 
father, and we did not see this in any of our mice. There are a varying number of mutations on 
each chromosome ranging from 1 to 11. However, there does not seem to be a saturation of 
genes on any of the chromosomes.  
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Figure 5. Graph of the number of disease-causing homozygous mutations on each mouse 
chromosome. 
3.3.1 Multihit disease-causing genes 
There are twelve disease-causing genes in which we have identified more than one mutation. 
Table 74 shows these twelve genes as sorted by the gene size. The number of alleles in this table 
is the number of different mutations that were recovered. 
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 Table 74. Disease-causing genes with multiple mutations as sorted by gene size. 
Gene Chr Gene Size (CDS) 
Human 
Ortholog 
Number 
of Alleles 
Wdr69 1 933 DAW1 2 
Dnaic1 4 2106 DNA1 2 
Gm1060/Drc1 5 2262 CCDC164 2 
Ccdc39 3 2814 CCDC39 3 
Bicc1 10 2934 BICC1 2 
Tmem67 4 2988 TMEM67 2 
Smarca4 9 4845 SMARCA4 2 
Pcsk5 19 5634 PCSK5 3 
Cep290 10 7440 CEP290 3 
Megf8 7 8370 MEGF8 2 
Dnah11 12 13467 DNAH11 8 
Dnah5 15 13866 DNAH5 9 
3.3.1.1 Bicc1—1 splicing and 1 missense mutation 
The Bicc1 missense mutation in exon 6 is located in a KH domain, which binds RNA and can 
function in RNA recognition (Garcia-Mayoral 2007).  The phenotype caused by this mutation is 
laterality. 
 
Figure 6. Bicc1 mutations are located in KH domain and in an unknown domain. 
3.3.1.2 Ccdc39—1 splicing, 1 nonsense, and 1 missense mutation 
The missense mutation in Ccdc39 occurs in the first amino acid, however it is not found in a 
functional domain. The phenotype caused by this mutation is SIT, or situs inversus totalis. The 
nonsense mutation in exon 4 is found just before a coiled coil domain. The phenotype involved 
with this mutation is AVSD (atrioventricular septal defect) and laterality. 
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Figure 7. Ccdc39 mutations are all located in unknown domains. 
3.3.1.3 Cep290—2 splicing and 1 nonsense mutation 
The nonsense mutation in exon 34 is located in a coiled coil domain, which is involved in the 
regulation of gene expression. The phenotype associated with this mutation is mild laterality and 
cystic kidney. Both splicing mutations can also be found in coiled coil domains. 
 
Figure 8. All three of the Cep290 mutations are in coiled coil domains. 
3.3.1.4 Dnah5—3 splicing and 6 missense mutations 
The first Dnah5 splicing mutation is in exon 4, which is located in an unknown domain. The 
phenotype related to this mutation is PCD (primary cystic kidney) and laterality. The second 
Dnah5 splicing mutation is located in exon 44 in an AAA domain also known as ATPases 
associated with a variety of cellular activities. The phenotype involved with this mutation is 
laterality defects. 
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 The first missense mutation is in exon 19 which can be found in the MBT (SM005561) 
and L27 (SM00569) domains. The MBT domain, malignant brain tumor, encodes a protein 
involved in transcriptional regulation. The L27 domain is involved in protein binding. The next 
missense mutation is located in exon 34 which can be found in the FYVE (SM00064) domain. 
This encodes a zinc finger protein, which binds two zinc ions. The next missense mutation is 
located in exon 48 which can be found in the AAA (SM00382) domain that codes for ATPases 
involved in a variety of cellular processes such as membrane fusion, proteolysis, and DNA 
replication. The phenotype associated with this mutation is PCD and laterality. The next 
missense mutation is located in exon 59, which is found in both the DHC-N1 and BRLZ 
domains. The DHC-N1 (PF08393) domain stands for dynein heavy chain, N-terminal region 1 
and is known to mediate interactions with other heavy chains and intermediate-light chain 
complexes. The BRLZ (SM00338) domain, or basic region leucine zipper, regulates the basic-
leucine zipper (bZIP) transcription factors (Hurst 1995). The phenotype involved with this 
mutation is DORV (double outlet right ventricle), AVSD (atrioventricular septal defect), and 
laterality defects.  
The following missense mutations and splicing mutation are located in the dynein heavy 
domain. The protein encoded by this domain is involved in ATPase activity, microtubule 
binding, and acts as a dynein motor for the movement of organelles and vesicles along 
microtubules (SMART). More importantly, dynein is involved in cilia and flagella movement, 
which have been proven to be involved in cardiac development (Hornef 2006). 
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Figure 9. Dnah5 gene has 9 different mutations that are all in functional protein domains. 
3.3.1.5 Dnah11—2 splicing mutations, 3 nonsense mutations, and 3 missense mutations 
The first splicing mutation is located in exon 7 which can be found in the DHC-N1 domain. The 
second splicing mutation is in exon 40 which can be found in the AAA-5 domain. You can see a 
description of these two domains in the Dnah5 section above. The mice with these mutations 
have laterality defects. 
 The three nonsense mutations are all located in functional domains, two of which are in 
the same domain. The first nonsense mutation is in exon 16 which can be found in the Spc7 
(SM00787) domain. This domain encodes a kinetochore protein and is required for kinetochore-
spindle association (Kerres 2004). The mice with this mutation have laterality defects. The next 
two nonsense mutations are in exons 60 and 63, which can both be found in the MYSc 
(SM00242), myosin ATPases, domain. This domain encodes the myosin protein, which forms 
the thick filaments of the myofibril, which is involved in muscle contraction (Hayashida 1991). 
The phenotype for the first nonsense mutation is laterality and OFT (outflow tract). The 
phenotype for the second nonsense mutation is laterality and PCD. 
 There are three missense mutations, which are all found in different exons in different 
protein domains. The first missense mutation is located in exon 33 in the AAA domain. Please 
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 see the explanation of the function of this domain in the Dnah5 section. The next missense 
mutation is found in exon 41 in the AAA-5 domain. This domain has the same function as the 
AAA domain. The third missense mutation can be found in exon 64, which is in the MYSc 
domain. This domain function is explained earlier in this section. All of these mutations are 
associated with laterality defects except the mutation in the MYSc domain also has PCD in 
addition to laterality. 
 
Figure 10. Dnah11 gene has 8 different mutations that are all located in functional domains. 
These domains include DHC_N1, Spc7, AAA, and MYSc. 
3.3.1.6 Dnaic1—1 splicing mutation and 1 missense mutation 
The Dnaic1 missense mutation is located in a WD40 (SM00320) domain, which is involved in 
protein binding. The phenotype for this mutation is laterality defects. 
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Figure 11. The Dnaic1 missense mutation is in a WD40 domain.  
3.3.1.7 Gm1060—2 missense mutations 
Both Gm1060 missense mutations are located in unknown protein domains. They are within four 
amino acids of one another in the same exon. This exon occurs just before a coiled coil domain 
so these mutations may affect that domain. 
 
Figure 12. Neither of the Gm1060 missense mutations is in functional domains. 
3.3.1.8 Megf8—2 missense mutations 
Both of the Megf8 missense mutations are in EGF domains. The first mutation is in exon 3 
which can be found in the first EGF (SM00181) domain for this gene. The EGF domain does not 
have a functional significance yet so it is difficult to determine how this causes the observed 
phenotype. The second mutation is in exon 21 which can be found EGF_Lam domain. This 
domain stands for laminin-type epidermal growth factor-like domain. Laminins are involved in 
mediating cell adhesion, growth migration, and differentiation (Beck 1990). These two mutations 
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 however have different phenotypes. The mutation in exon 3 has several cardiac defects such as 
dextrocardia, AVSD, DORV, and SIT. The mutation in exon 21 only has laterality defects. 
 
Figure 13. Both Megf8 missense mutations are in EGF domains. 
3.3.1.9 Pcsk5—3 missense mutations 
Two of the Pcsk5 missense mutations are in FU (SM00261) domains, although these domains 
are far apart across the gene. The FU domain stands for furin-like repeats which are involved in 
signal transduction by receptor tyrosine kinases (Raz 1991). The phenotype for the missense 
mutation in exon 22 is VSD (ventricular septal defect) and cystic kidney. The phenotype for the 
mutation in exon 35 is DORV, VSD, and aortic stenosis. 
 The other missense mutation occurs in exon 4 in the Peptidase_S8 domain. This domain 
is a part of the subtilase family, which is composed of serine proteases. The phenotype 
associated with this mutation is laterality defects, OFT, and cystic kidney. 
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Figure 14. Two of the Pcsk5 missense mutations are in FU domains and the other is in a 
Peptidase_S8 domain. 
3.3.1.10 Smarca4—2 missense mutations 
The first missense mutation in Smarca4 at exon 8 is located in a low complexity region, which 
does not seem to have any function relevance to causing the phenotype. The second missense 
mutation at exon 16 is located in the DEXDc (SM00487) and SNF2_N domains. The DEXDc 
domain stands for DEAD-like helicases superfamily and encodes DNA and RNA helicases, 
which catalyze the separation of double-stranded nucleic acids (Caruthers 2002). 
The SNF2_N domain is involved in several processes such as transcription regulation, DNA 
repair, DNA recombination, and chromatin unwinding among other minor processes (Pfam). The 
phenotype for this gene is outflow tract in both mutations.  
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Figure 15. One Smarca4 mutation is located in two functional domains: SNF2_N and DEXDc. 
3.3.1.11 Tmem67—1 splicing and 1 missense mutation 
Both mutations in Tmem67 are located in the Meckelin (PF09773) domain; however the two 
mutations are fairly far apart because this domain is very large spanning almost the entire gene. 
The phenotype associated with the mutation in exon 11 is laterality and cystic kidney. The 
phenotype associated with the splicing mutation in exon 23 is laterality defects. The Meckelin 
domain is known to be associated with the basal ciliary body. 
 
Figure 16. Both mutations in Tmem67 are in the Meckelin domain. 
3.3.1.12 Wdr69—1 nonsense and 1 missense mutation 
The nonsense mutation located in exon 2 is located in an unknown domain. The phenotype 
associated with this mutation is laterality defects and kidney tubule cysts. The missense mutation 
in exon 3 is found in a WD40 domain. The phenotype related to this mutation is laterality 
defects. 
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Figure 17. Wdr69 gene has a missense mutation in the WD40 domain and a nonsense mutation 
in an unknown domain. 
3.3.2 Splicing Mutations 
There are a total of 16 disease-causing splicing mutations that are described in Table 75. One 
quarter (25%) of these mutations are not within the two base pair canonical splicing sites. Almost 
all of the splicing mutations are at a conserved residue, with the exception of three mutations. 
The rest of the splicing mutations are in at least somewhat conserved regions as you can see in 
Table 75. There are four splicing mutations, which are not located in the canonical splice sites. 
The splicing mutations that are mostly conserved have a few changes in the wild type nucleotide 
at that position, but none that are the same as the mutation in our variant. Donor splicing 
mutations occur at the 5’ end, or beginning, of the intron whereas acceptor splicing mutations 
occur at the 3’ end, or the end, of the intron. 
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 Table 75. Evolutionary conservation of splicing mutations in disease-causing genes. 
 
Gene 
 
Chr 
 
Position 
Nucleotide 
Change 
Number 
of bases 
from exon 
Splicing 
Site 
Affected 
Conserved 
Residue 
Dnaic1 4 41544973 c.240+1G>A 1 Donor Conserved 
Gm572 4 148017493 c.26+1G>A 1 Donor Conserved 
Bicc1 10 70420407 c.606+2T>C 2 Donor Conserved 
Ccdc39 3 33737998 c.357+2T>A 2 Donor Conserved 
Ccdc151 9 21799255 c.828+2T>C 2 Donor Conserved 
Cep290 10 99962906 c.1189+2T>C 2 Donor Conserved 
D630037F22Rik 10 55915160 c.1071+2T>A 2 Donor Conserved 
Dnah11 12 119425356 c.1137+2T>C 2 Donor Conserved 
Dnah11 12 119282224 c.6489+2T>C 2 Donor Conserved 
Dnah5 15 28159416 c.438+2T>A 2 Donor Conserved 
Dnah5 15 28275670 c.7398+2T>A 2 Donor Conserved 
Fuz 7 52152701 c.387+2T>A 2 Donor Conserved 
Lrp2 2 69316757 c.8456-3A>G 3 Acceptor Mostly conserved 
Tmem67 4 11974951 c.2322+6T>C 6 Donor Mostly conserved 
Dctn5 7 129281879 c.348+6T>C 6 Donor Mostly conserved 
Dnah5 15 28388293 c.13329-10T>A 10 Acceptor Conserved 
 
The following table shows three candidate genes that were recovered as splicing mutations in our 
screen. These three mutations are not conserved and would be considered tolerated under the 
conservation rules upon looking at the nucleotide change. These three mutations all have the 
nucleotide change as the wild type nucleotide in other species. In particular, the Kif15 mutation 
is present as wild type in all other species except the mouse. Upon further analysis, it was found 
that these mutations were not actually the cause for disease in the mice. This provides further 
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 evidence that mutations, even in splicing regions, which are disease causing do not generally 
occur at a position where the change is present as the wild type. 
Table 76. Nucleotides across the set of species for non-conserved splicing mutations. 
Gene Cypc2c44 Cep290 Kif15 
Chromosome 19 10 9 
Nucleotide change T>A C>T C>T 
Number of bases 
from exon 4 7 8 
Mouse T C C 
Rat T T - 
Human T C T 
Orangutan T C T 
Dog = C T 
Horse T C T 
Opossum A A T 
Chicken C = = 
Stickleback  =  
Red lettering indicates a non-conserved residue 
Bold means these nucleotides are the same as the nucleotide change observed. 
 
The Cyp2c44 gene has a non-conserved mutation four base pairs from the exon located in 
an intronic region within the p450 protein domain. This mutation is present in two mice from 
line 386 who both have DORV, double outlet right ventricle. The nucleotide changes from a 
thymine to an adenosine in mice; however adenosine is the wild type nucleotide in the opossum. 
Since the opossum is lower on the species list, it is safe to assume that this mutation may still be 
disease causing. 
The Cep290 gene has a mutation seven base pairs from the exon located in the intronic 
region of a coiled coil protein domain. This mutation is present in one mouse line with a 
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 phenotype of hypertrophy, craniofacial defects, and laterality defects. The mutation changes the 
wild type cysteine nucleotide to a tyrosine. This mutation may be tolerated because the tyrosine 
is present as the wild type nucleotide in the rat. 
The Kif15 gene has a mutation eight base pairs from the exon located in the intronic 
region before the kinesin protein domain. This mutation is present in two different mouse lines; 
one mouse has laterality defects and the other mouse has PTA and pulmonary atresia with 
MAPCA. The base pair changes from a cytosine to a thymine in our mouse model. This 
particular mutation is definitely not conserved because the nucleotide change, thymine, is the 
wild type nucleotide in all other species, not including the rat and stickleback which do not have 
nucleotide information at that position. Due to the fact that this mutation is present in two mouse 
lines with different phenotypes and the conservation information, it is very unlikely that this 
mutation is disease causing. 
3.4 MOUSE AND HUMAN MUTATION CORRELATION 
The following table (Error! Reference source not found.) gives a comparison of the recovered 
ENU mutations with published human mutations. We were able to recover several mutations in 
our screen that are in the same domain as the human mutations. Within that subsection, we also 
recovered a few mutations that are a few amino acids apart and have similar phenotypes. The 
genes in which these mutations occur include: Cc2d2a, Ccdc39, Smarca4, and Tmem67. 
 The Cc2d2a gene contains a homozygous nonsense mutation at position 949 (R949X) in 
the mouse and at position 950 (R950X) in humans. There are similar phenotypes in mice and 
humans; mice have mild laterality, cystic kidney, and cystic lung while humans have retinal 
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 dystrophy, renal disease, and molar tooth sign from MRI. Both mice and humans have some 
form of renal defect. Unfortunately, these mutations occur in unknown domains within this gene. 
 The Ccdc39 gene has a homozygous splicing mutation in mice two base pairs from intron 
4 while humans have a similar mutation one base pair from exon 4 that can be either 
homozygous or heterozygous. The phenotype in mice is laterality defects and in humans is 
Kartagener syndrome, SIT, and Ivemark syndrome, all of which are caused by laterality defects.  
 The Smarca4 gene has a heterozygous missense mutation at position 766 (V766G) in 
mice whereas humans have a missense mutation one amino acid earlier at position 764 (W764R) 
with unknown zygosity. Unfortunately the phenotype was not explained by Medina, so we 
cannot compare it with the mouse phenotype. However, this mutation occurs in the DEXDc 
protein domain which, as explained earlier, encodes helicases which catalyze the separation of 
double stranded nucleic acids. 
 The Tmem67 gene was found to have mutations in the Meckelin protein domain in both 
humans and mice. The homozygous mouse mutation is found in exon 11 at position 374 
(Y374N) whereas the heterozygous human mutation is found in the amino acid before that at 
position 372 (T372K). The human mutation has a vast range of phenotypic anomalies with this 
mutation including molar tooth sign, retinal abnormalities, cystic kidney, elevated liver enzymes, 
and hepatosplenomegaly. The mouse phenotype simply consists of a cystic kidney, similarly to 
the human, and laterality defects.  
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Table 77. Disease-causing homozygous mutations recovered from ENU screen and published human mutations with similar phenotypes 
that are in the same protein domains. 
Gene Zygosity Location Nucleotide Change 
Amino 
acid 
change 
Domain Mouse/Human Phenotype Citation 
ARMC4 - - T2780G L927W ARM PCD Hjeij 
Armc4 H Exon 20 T2978A M993K ARM Laterality - 
CC2D2A H - - R950X unknown 
Retinal dystrophy, 
renal disease, molar 
tooth sign from MRI 
Gordon 
Cc2d2a H Exon 23 C2845T R949X unknown Mild laterality/cystic kidney & lung - 
CCDC39 H/R Intron 3 357+1G>C - intronic 
Kartagener, SIT, 
Ivemark—laterality 
defects 
Blanchon 
Ccdc39 H Exon 4 357+2T>A - intronic Laterality - 
CEP290 R Exon 36 A4723T K1575X CCD 
LCA, mental 
retardation, molar 
tooth sign, muscular 
weakness 
Perrault 
Cep290 H Exon 34 T4670A L1557X CCD Mild laterality/ Cystic kidney - 
Dnah11 H Exon 64 - A3474T unknown - Bartoloni 
DNAH11 - Exon 64 G10284A G3429R unknown - Pifferi 
Dnah11 H Exon 64 A10369T I3457F unknown PCD/Laterality - 
DNAH11 R Exon 60 T9764C L3255S unknown Situs solitus Knowles 
Dnah11 H Exon 63 C10243T Q3415X unknown PCD/Laterality - 
DNAH5 R Exon 48 A7888T R2630W AAA - Failly 
Dnah5 H Exon 48 T7971G N2657K AAA PCD/Laterality - 
DNAH5 R Exon 73 G12614T G4205V Dynein heavy - 
Failly & 
Hornef 
Dnah5 H Exon 76 T13169C L4390P Dynein heavy PCD/Laterality - 
Dnah5 H Exon 76 T13210A S4404T Dynein heavy PCD/Laterality - 
DNAH5 H/R Intron 76 13338+ 5G>A - 
intronic/ 
dynein 
heavy 
- Failly & Hornef 
Dnah5 H Exon 77 T13329A - 
intronic/ 
dynein 
heavy 
PCD/Laterality - 
DNAI1 R Exon 16 G1543A G515S unknown SIT, respiratory complications 
Guichard 
& 
Zietkiewicz 
DNAI1 R Exon 16 T1538C L513P unknown - Zietkiewicz 
Dnaic1 H Exon 16 T1565C I522T unknown Laterality - 
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 Table 77. Continued 
DYNC2H1 R Exon 57 A9044G D3015G unknown ATD; scoliosis, syndactyly 
Dagoneau 
& 
Schmidts 
Dync2h1 R Exon 57 G9031T V3011L unknown Unbalanced AVSD - 
DYNC2H1 H Exon 6 C988T R330C DHC_N1 Scoliosis, syndactyly 
Schmidts 
& 
Hokayem 
Dync2h1 H Exon 5 T701A V234E DHC_N1 Mild Laterality - 
FREM2 - Exon 5 C5914A E1972K Calx-beta 
Syndactyly, 
cryptophthalmos, 
urinary 
tract/ear/nose/lung 
abnormalities 
Van Haelst 
Frem2 H Exon 11 A6875G Y2292C Calx-beta  
Kidney 
agenesis/syndactly/ 
polydactyly 
- 
IFT140 R - A932G Y311C unknown Mainzer-Saldino syndrome Perrault 
Ift140 H Exon 9 A1138G N380D unknown Laterality - 
MEGF8 H -  G595C G199R EGF 
craniosynostosis, 
prominent forehead, 
5th finger 
clinodactyly, preaxial 
polydactyly, 
dextrocardia w/ SIT, 
bilateral 
cryptorchidism, wide-
spread nipples 
Twigg 
Megf8 H Exon 3  A442G N148D EGF 
SIT, AVSD, 
dextrocardia, DORV - 
PRICKLE1 - Exon 3 G361A V121I LIM *Predicted as benign & tolerant Bosoi 
PRICKLE1 - Exon 3 G370A A124T LIM *Predicted as benign & tolerant Bosoi 
Prickle1 H Exon 5 G482T C161F LIM Velocardiofacial Syndrome - 
SMARCA4 - Exon 16 T2290A W764R DEXDc - Medina 
Smarca4 R Exon 16 T2297G V766G DEXDc DORV, VSD, cystic kidney - 
Smarca4 H Exon 16 C2381T T794I 
DEXDc 
& 
SNF2_N 
DORV, VSD - 
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 Please see Appendix A for full domain and phenotype information.  
H-homozygous, R-heterozygous. 
Yellow highlighted mutations are within 2 amino acids of one another. 
Phenotypes in bold are the same in both the mouse and human for that gene. 
TMEM67 H Exon 10 T1046C L349S Meckelin 
encephalomeningocel
e, bile duct 
proliferation, cleft 
palate, bile duct 
proliferation, 
tetralogy of Fallot 
*Predicted as 
possibly damaging 
Iannicelli 
TMEM67 R Exon 11 C1115A T372K Meckelin 
Molar tooth sign, 
chorioretinal 
colobomas, chronic 
renal insufficiency, 
cystic kidney, 
elevated liver 
enzymes, 
hepatosplenomegaly 
Iannicelli 
Tmem67 H Exon 11 T1120A Y374N Meckelin Laterality/cystic kidney - 
Table 77 Continued 
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 4.0  DISCUSSION 
As you can see in Figure 4 and Figure 5, there is no saturation of disease-causing genes on any 
specific chromosome. However, we did not recover any genes the sex chromosomes. This makes 
sense because any genes on only one of the sex chromosomes would have resulted in a lethal 
phenotype in males; this is not the case with our mutations. 
As for the mutation that is considered tolerated, I have no hypothesis as to why this is 
able to cause disease despite the fact that the mutated amino acid is present as a wild type in 
other species. Since it is a missense mutation, we cannot argue that there is an introduction of a 
stop codon that will truncate the protein. The mutation is found in two lesser known protein 
domains:  MBT and L27. The MBT, malignant brain tumor, domain is involved in 
transcriptional repression and chromatin modification. The L27 domain is found in receptor 
targeting proteins Lin-2 and Lin-7 as well as some protein kinases. 
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 5.0  CONCLUSIONS 
We conducted a forward genetic screen using ENU-induced mice in order to find the majority of 
disease-causing genes for congenital heart defects. We were able to recover a total of 88 different 
mutations within 62 disease-causing genes that contribute to both cardiac and non-cardiac mutant 
phenotypes from nearly 150 mouse lines.  
 Out of the 1,338 homozygous variants we recovered 96 (7.2%) disease-causing variants 
from sixty-five genes. Of these variants, 59 were missense, 16 were splicing, and 13 were 
nonsense. There were 8 variants that are the same, either occurring in the same mouse line but 
different mice or in different mouse lines. This gives us a final count of 88 different disease-
causing variants in 62 genes.  
There are 21 mutations from our screen that were found to be similar to previously 
published human mutations. The mutations are similar in the sense that they occur in the same 
protein domain, but not necessarily the same exon. These mutations also present similar 
phenotypes in both mice and humans. Three of these mutations are incredibly similar to 
published human mutations due to the fact that they are within one or two amino acids or 
nucleotides from each other. 
All in all, we can conclude that the 88 disease-causing mutations recovered from our 
genetic screen are mostly damaging. Three-fourths (75%) of the mutations were completely 
damaging. About 17% were possibly damaging, 2% were possibly tolerated, and 1% was 
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 tolerated. The remaining 5% are splicing mutations that were more than two base pairs from the 
exon and therefore did not have a definitive conservation call. Overall, there is only one mutation 
in our screen that was tolerated.  
This information proves that mutations which are disease causing generally occur in 
highly conserved amino acids across a set of species. It has been previously theorized that there 
is biological significance in having mutations with  
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 APPENDIX A: FULL DOMAIN NAMES FROM TABLE 1 
7tm_1—7 transmembrane receptor (rhodopsin family) 
AAA— ATPase family associated with various cellular activities 
AAA_5—AAA family-5 
Acetyltransf_1—acetyltransferase (GNAT) family 
Adaptin_N—adaptin N terminal region 
ANK—ankyrin repeat 
ARM—armadillo/beta-catenin-like repeat 
B41—band 4.1 homologues 
Calx-beta—Calx-beta domain 
CCD—coiled coil domain 
DEXDc—DEAD-like helicases superfamily 
DHC_N1—dynein heavy chain, N-terminal region 1 
DUF3585—domain of unknown function 3585 
Dynein heavy—dynein heavy chain and region D6 of dynein motor 
EGF—epidermal growth factor-like 
FH—forkhead 
FR47—FR47-like protein 
FU—furin-like repeats 
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 HDc—metal dependent phosphohydrolases with conserved ‘HD’ motif 
HECTc—domain homologous to E6-AP Carboxyl terminus 
IGc2—immunoglobulin C-2 type 
KH—K homology RNA-binding domain 
KISc—kinesin motor, catalytic domain, ATPasw 
LDLa—low-density lipoprotein receptor domain class A 
LIM—zinc-ion binding domain present in Lin-11, Isl-1, Mec-3 
LINK—LINK (hyaluronan binding) 
Lysl_oxidase— 
Meckelin—Meckelin (transmembrane protein 67) 
P450—cytochrome p450 
Pep_M12B_propep—reprolysin family propeptide 
Peptidase_M24— metallopeptidase family M24 
Peptidase_S8—subtilase family 
Plexin_cytopl—plexin cytoplasmic RasGAP domain 
PP2Cc—serine/threonine phosphatases, family 2C, catalystic domain 
Sema—semaphorin domain 
SNF2_N—SNF2 family N-terminal domain 
S_TKc—serine/threonine protein kinases, catalytic domain 
SUFU—suppressor of fused protein 
Tryp_SPc—trypsin-like serine protease 
ZnMc—zinc-dependent metalloprotease 
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 APPENDIX B: PHENOTYPE ACRONYMS 
ASD—atrial septal defect 
ATD—asphyxiating thoracic dystrophy 
AVSD—atrioventricular septal defect 
DORV—double outlet right ventricle 
D-TGA—dextro-transposition of the great arteries 
HLHS—hypoplastic left heart syndrome 
HRHS—hypoplastic right heart syndrome 
IAA—interrupted aortic arch 
LCA—Leber congenital amaurosis 
MAPCA—major aortopulmonary collateral artery 
OFT—outflow tract 
PCD—primary ciliary dysfunction 
PKD—primary cystic kidney disease 
PTA—percutaneous transluminal angioplasty 
RAA—right aortic arch 
SIT—situs inversus totalis 
TGA—transposition of the great arteries 
VSD—ventricular septal defect 
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